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Abstract 
 
Culturing neurons in vitro is a challenging task because they are a highly specialized cell 
type that reside in a complex and unique environment in the body. The aim of the 
research presented in the following thesis was to design a biomimetic, three-dimensional 
scaffold capable of (1) promoting primary neuron maturation and axonal outgrowth and 
(2) serving as a system for toxicology screening. In the system presented here, neurons 
were cultured in three-dimensional hydrogels, simulating the physiological environment 
that these cells experience within the body. In doing so, a biologically relevant response 
was elicited upon their exposure to acrylamide, a known neurotoxin. Primary neurons 
were isolated from embryonic chick spinal cords and seeded in alginate or collagen 
hydrogels. Initial cell viability assays and qualitative microscopy observations confirmed 
that primary neurons not only survive in the system, but also exhibit positive axon 
growth. Next, neuronal response to acrylamide was evaluated through cytotoxicity assays 
and axon outgrowth measurement through immunocytochemistry. The study of 
neurotoxic effects on neuron maturation in collagen gels yielded two key observations: 
(1) the level of cell death in neurons exposed to acrylamide is dependent on the density 
and availability of attachment proteins in the collagen hydrogel environment and (2) the 
axonal retraction response is more sensitive to acrylamide than the lethal cellular 
response is. The ability of the collagen scaffold to provide insight into neuronal response 
to toxin in a biomimetic, three-dimensional environment suggests the system’s potential 
for increasing the accuracy of early stage cytotoxicity testing for safe and efficient 
pharmaceutical candidates. Additionally, this research has further implications in 
neurodegenerative disease modeling, spinal cord injury recovery studies, and basic 
research in neuroscience and neural tissue engineering. 
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1. Introduction 
 
1.1 Background and Motivation 
Fundamentally, this project involves the culturing of primary neurons in three-
dimensional hydrogel matrices. It is our intention to mimic the physiological environment 
that these cells experience within the body, hoping that such an environment would elicit 
a biologically relevant response to neurotoxins. Our project is ultimately motivated by the 
need for more efficient and economical pharmaceutical development. A more robust  in 
vitro testing method, such as the one we are proposing, would potentially reduce animal 
testing, which is an expensive component of drug development, and also provide more 
accurate information about the neurotoxicity of compounds to humans than what can be 
determined from non-human animal models. Ideally, the system could take the place of 
animals during the early drug candidate identification stages of development, since this is 
when many compounds are screened to assess their toxic and clinical profile. We would 
like our in vitro system to rule out toxic drug candidates and refine the selection process 
before further testing is performed on animal models. Overall, this project will advance 
the ability to study neuronal cell types in vitro, and benefit pharmaceutical developers 
and consumers. 
 
1.2 Literature Review of the Field 
1.2.1 The central nervous system environment 
The central nervous system (CNS), which includes the brain and spinal cord, has several 
features that give rise to a highly specialized cellular environment. The CNS is enveloped 
by three meninges, layers of connective tissue that isolate and protect the nerve tissues. 
The bundled nerve fibers of the spinal cord are additionally protected by the vertebral 
bones of the spinal column. The brain and spinal cord are bathed in cerebrospinal fluid. 
The tight maintenance of this chemical environment is called the blood brain barrier and 
is a unique aspect of the CNS that is difficult to replicate outside the body. 
 
Animal tissues are comprised of cells and the extracellular space, the latter of which is 
filled with a network of macromolecules called the extracellular matrix (ECM). The 
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ECM that is found in the brain and spinal cord is markedly different from the ECM in 
other tissues. While structural proteins elastin, collagen, and fibronectin are large 
components of most ECMs, in the spinal cord glycosaminoglycans—namely, hyaluronic 
acid, and proteoglycans such as aggrecan, brevican, agrin, and neurocan—are most 
common [1]. Laminin has a significant presence in generic ECM and is also widely 
expressed in the spinal cord, especially during embryogenic development. The ECM 
proteins form a loose meshwork, shown in Figure 1, which comprises 20% of the tissue 
volume. It is important to note that neural ECM varies in composition from the 
developmental period to adult form [1]. 
 
 
Figure 1. Schematic drawing of the major ECM proteins of the CNS [30] 
 
The ECM plays a crucial role in guiding progenitor cell migration and differentiation, is 
involved in regulating cell behaviors, and facilitates cell attachments which are required 
for neuron survival and mature morphology. Additionally, the ECM stores caches of 
growth factors and cytokines that can be proteolytically released under specific 
conditions such as injury [2]. 
 
Fascinating studies in recent years have revealed the preferences of certain cell types for 
different substrate stiffnesses. Mechanical cues from the culture surface can even be 
sufficient to direct stem cell differentiation. Substrates on the softer end of the spectrum, 
less than 1 kPa, have been shown to promote the differentiation of neural stem cells into 
neurons instead of astrocytes (glial support cells) and to support axon outgrowth much 
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more than stiffer substrates. A study from Northwestern University in 2013 found the 
average length of the longest neurite per cell on soft PA (peptide amphiphile material) to 
be 76.3 ± 1.9 µm,  nearly double compared with stiff PA (42.5± 1.3 µm, p < 0.001) [3]. 
These findings make sense because soft gels and surfaces approximate the soft nature of 
nervous system tissues in vivo. CNS tissue has a Young’s elastic modulus range of 0.1-1 
kPa [4]. There are an array of strategies for characterizing the mechanical properties of 
neural tissue, so measurements of shear and elastic moduli vary from source to source. 
Table 1 presents stiffness data pertaining to the spinal cord.  
 
Table 1. Test methods and relative spinal cord tissue measurements [4] 
 
 
1.2.2 Chick embryology 
Chick embryos are a useful tool for research because they are a relatively accessible 
source of tissue, their development can be timed based on extensive previous research, 
and the stage of embryonic development can be easily determined using Hamburger and 
Hamilton’s explicitly defined stages [5, 6]. The chick is also a good model to represent 
many other types of vertebrate development. As with all vertebrates, there are three main 
types of tissue that arise early in development: the endoderm, the ectoderm, and the 
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mesoderm. From these tissue types all other tissues are generated. One of the first notable 
moments in development is the formation of the neural tube, as diagramed in Figure 2. 
For our area of study this is a key aspect because the neural tube will soon differentiate 
into the spinal cord, from which primary neurons can be isolated. In chick embryos, 
neurogenesis is complete by ‘E9’—embryonic day nine of incubation, when the spinal 
cord is intact but myelination has not occurred [7].  
 
 
Figure 2. Formation of the neural tube [8] 
 
1.2.3 Primary neuron culture 
Primary neurons, like any cell type, require ample supply of specific nutrients to survive. 
A general protocol consists of culturing primary neurons in Neurobasal media with B27 
supplement. Other supplements can be added such as glutamine, glutamate, ampicillin, 
and streptomycin for additional nutritional and antibiotic needs [9, 10]. O’Connor et al. 
suggest plating  2x10
5
 cells/ ml in a 24-well plate [9]. A higher cell density might be 
preferred to assure sufficient cell attachment and survival. This paper also suggests the 
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following incubator conditions for optimal cell culture: 37°C, 5% CO2, 20% O2, and 99% 
relative humidity [9]. 
 
While primary neurons are a sensitive cell type that can be relatively difficult to maintain 
in vitro, culture methods have been established, as introduced above. O’Connor et al. 
found that rat cortical neurons remained viable in pure collagen gels for up to 14 days, 
but were not viable in pure agarose gels [9]. Additionally, Matyash et al. found that soft 
alginate hydrogels supported the survival and neurite outgrowth of rat and human 
neurons, and their results suggest that in serum-free conditions non-functionalized 
alginate provides neuritogenic and neuroprotective effects [10]. Also of interest are the 
findings of Lai et al., who found that primary mouse superior cervical ganglion neurons 
could be cultured in 3D poly-L-lactic acid and polystyrene scaffolds, where they exhibit 
more biologically-relevant voltage-gated calcium channel function than the same cells 
cultured in 2D [11]. Lastly, in 2010 Gotte et al. established a protocol for culturing 
primary rat cerebellar granule neurons in a relatively high-throughput 2D 96-well format, 
enabling neurotoxicity screening with a cellular imaging-based assay [12]. 
 
1.2.4 Scaffold biomaterials and ECM proteins 
Neural tissue engineering employs biomaterial scaffolds to develop advanced 
cytotoxicity assays, to evolve novel therapies against neurodegenerative diseases, and to 
study neuronal differentiation and proliferation mechanisms. The cutting-edge materials 
for tissue scaffolds are commonly hydrogels, which are polymer networks swollen with 
water. Hydrogels enable encapsulation of cells in a three-dimensional environment—an 
intrinsically more biologically relevant system than a flat culture plate. Cells grown on 
flat 2D substrates tend to differ considerably in their differentiation, morphology, and 
cell-cell and cell-matrix interactions from those grown in more physiological 3D 
environments [10, 13]. Moving to 3D cultures better replicates in vivo complexity, 
facilitating multi-dimensional physiochemical cues, cellular migration in the z-plane, and 
controlled diffusion of small and large molecules [14]. Dimensionality plays a significant 
role in neuron maturation; neurons have been shown to extend and retract their axons 
more dynamically in soft 3D matrices than on 2D substrates [13]. 
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Alginate is a natural, anionic polysaccharide derived from algae. It is made up of (1-4)-
linked β-D-mannuronic acid and α-L-guluronic acid, arranged variably along the polymer 
chain [15]. Alginate molecules can be cross-linked via divalent cations, such as Ca
2+
, into 
three-dimensional water-containing gels with tunable stiffness and pore size. Such 
alginate hydrogels are synthetic extracellular matrices capable of encapsulating cells in 
three dimensions. They have been used extensively in cell culture research. However, 
mammalian cells are largely unable to form attachments to alginate itself, and cell-ECM 
adhesions are critical for cell migration, proliferation, and anti-apoptotic cellular 
signaling pathways [14]. Therefore, extracellular matrix proteins with recognizable 
adhesion sites must be incorporated into alginate scaffolds to make them fully “liveable” 
environments for cells [15]. 
 
We initially chose to look into the effects of collagen, laminin, and fibronectin 
extracellular matrix proteins on neuron maturation and extension because of the existing 
research supporting their potential in neural applications. Collagen is most prevalent in 
bone and skin tissue, thus comprising roughly 25% of the protein mass in animals. There 
are many types of collagens; however, they all have the same general structure of 3 α-
helical polypeptide chains wrapped around each other, forming a left-handed superhelix 
[16]. The difference in the types of collagens is due to the varying lengths of the helical 
and non-helical sections and the amount of carbohydrates attached to the helical part [17]. 
The function of collagen is to strengthen the ECM by making it more resistant to tensile 
forces. In order to accomplish this, individual collagen fibers form crosslinks between 
lysine residues, ultimately forming a stable fibril. 
 
For neural engineering purposes, collagen has been used alone or in co-gels with other 
ECM proteins, such as laminin and fibronectin, which will be discussed shortly. Collagen 
gels were designed based on the principle that collagen fibrils form mesh structures. 
Collagen is primarily used to create a mechanically stable scaffold, while the other ECM 
additives were tested for their ligand density and biochemical affinity. In 2007, Deister et 
al. showed that 0.5 mg/mL collagen did not produce a mechanically stable gel, but 
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concentrations from 1-2.5 mg/mL did. Neurite length and outgrowth at these 
concentrations did not significantly vary [18]. 
 
It has also been shown that collagen alone can form a stable gel that is sufficient for 
neuron survival and differentiation when compared to an agarose (polysaccharide) gel. 
O’Connor et al. demonstrated that culturing cortical rat neurons in 0.4 mg/mL collagen 
resulted in a reduced incidence of apoptosis [9]. In this study, the high amount of 
substrate for cell adherence provided by collagen led to a greater percentage of cell 
survival compared to agarose. They also showed that as collagen concentration increased, 
neurite length decreased, which is attributed to the decreasing pore size of the gel at 
higher concentrations that may obstruct axon extension [9]. These findings suggest that 
collagen is an appropriate ECM protein for the use of primary neuron culture at certain 
concentrations. Additionally, this paper led to our interest in the effect of combining a 
structural ECM protein with a polysaccharide gel on neurite outgrowth and length.   
 
Fibronectin is a glycoprotein comprised of a pair of subunits approximately 250 kDa in 
size each, which are linked by disulfide bonds [19]. In addition to playing a role in wound 
healing, fibronectin is integral in cell adhesion, migration, and differentiation [18, 20]. It 
is a substance that is found either as a solute in the blood or as a fibrous mesh in the 
extracellular matrix [20]. In the ECM, fibronectin provides attachment points for cells to 
anchor to each other and/or the basement membrane of the tissue. 
 
Several research articles and review papers on axon regeneration and spinal cord repair 
acknowledge the ability of fibronectin to induce and promote axon extension in vitro and 
in vivo [18, 19, 20]. In 2012, Tonge et al. verified the capacity of fibronectin and its 
fragmented variants to promote neuronal repair and extension; they reaffirmed the 
finding that the a5b1 integrin serves as a crucial fibronectin binding site on cell surfaces 
that is expressed on regenerating axons [19]. Their findings also suggest that fibronectin 
was a superior protein in promoting neurite extension compared to laminin in vitro [19].  
 
Meanwhile, a comprehensive study by Deister, Aljabari, and Schmidt (2007), examined 
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the effects of hydrogels containing multiple proteins; they found that co-gels of 
fibronectin and type I collagen were relatively inferior to laminin-collagen gels in terms 
of outgrowth percentage and overall length [18]. Furthermore, the study also found that 
increasing fibronectin concentration resulted in less growth [18]. In their discussion, 
Deister et al. explained that a critical balance between attachment and detachment 
mechanisms at the axon growth cone is necessary for growth. They then suggest that 
fibronectin may lead to stronger adhesion, thus resulting in excessive tension and, to 
some extent, may inhibit growth rather than promote it. Regardless, fibronectin is still a 
viable protein in obtaining neuron growth despite being inferior to laminin. 
 
Laminins are a family of cross-shaped glycoproteins found abundantly in extracellular 
matrices and basal lamina. Laminin networks are crucial for cell-ECM adhesion, and in 
the nervous system they make up a major component of embryonic CNS tissue, 
facilitating neuron-glial cell interactions [2]. Knocking out the B1 integrin that binds to 
laminin outside the cell membrane has shown that laminin is essential for neuron 
precursor cells to migrate and extend axons [2]. Deister et al. demonstrated that 
increasing the concentration of laminin on the substrate surface increased both the 
amount of neurite outgrowth and the average length of neurite extensions [18]. In 
addition, while collagen protein concentration significantly impacts the viscoelastic 
stiffness of the gel, laminin concentration does not because laminin fibers are not capable 
of cross-linking with themselves to form hydrogels like collagen [18]. Fibronectin is 
similar to laminin in this regard. The study found that laminin/collagen co-gels with 
increasing laminin concentration of 0.5, 1.0, and 1.5 mg/mL correlated linearly with 
neurite outgrowth; 1.5 mg/mL laminin yielded approximately 85% more neurite 
outgrowth than the collagen-only controls [18]. Laminin has repeatedly shown positive 
results for encouraging neuron growth. 
 
1.2.5 Neurotoxicity testing 
The field of cytotoxicity testing currently has several areas of great need. It is a high 
priority in industry to develop in vitro models for neurotoxicity screening that are more 
high-throughput and cost-effective. Most established in vitro neurotoxicity testing models 
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function as complementary and methods to in vivo tests and are useful for studying 
cellular mechanisms of toxicity, but it is desirable to have in vitro tests that can be used 
more predictively [21, 22]. However, none have been formally validated and standardized 
for this kind of application. Currently, in vivo testing on animals is the predominant 
method for evaluating the effects of toxins on neural behavior and pathology. As 
delineated by Bal-Price et al. in their review of in vitro neurotoxicity testing, 
comprehensive neurotoxicity tests need to (1) determine cell viability/death, (2) assess 
generic cell functions like metabolism, and (3) be able to detect neuron-specific functions 
such as neurotransmission and electrical activity [21].  
 
This is not to suggest that all the current challenges in neurotoxicity testing could be 
overcome with one “super assay.” Compounds must be studied with a combination of 
models, because toxicity in the central nervous system (CNS) and peripheral nervous 
system (PNS) may differ in terms of the LD50 (the lethal dose required to kill half of the 
tested population) and time frame of a toxic response [21]. In vitro blood brain barrier 
models have been developed to determine whether compounds enter the CNS, better 
representing the physiological complexity of the nervous system. However, the current 
approaches make testing methods too complex, precluding high-throughput applications. 
In the near future, new technologies of three-dimensional models containing advanced 
biomimetic elements or multiple cell types may be able to solve a lot of the limitations in 
in vitro neurotoxicity testing [21, 22]. Advanced in vitro systems address needs in the 
screening and categorization of neurotoxic effects on adult and developmental neural 
systems and hold great potential if they can be made more high-throughput and 
economical.  
 
To this end, three-dimensional biomaterial scaffolds are very promising because they 
more closely model actual physiological systems than two-dimensional systems do. 3D 
systems can generate information about cell viability and toxicity that is needed for 
accurate LD50 evaluation. In 2011, Lan et al. encapsulated HepG2 liver cells in alginate 
hydrogels in co-culture with MCF-7 cells, as well as in a 2D monolayer, and used the 
platform to test for cytotoxicity in the hepatocytes [23]. Commercially available drugs 
Acetaminophen, Diclofenac, Rifampin, and Quinidine were tested, and CT50 (the in vitro 
10 
equivalent of LD50) data were gathered. As seen in Figure 3 below, they found that there 
was a stronger in vitro - in vivo correlation for the cells cultured in 3D (R
2
>0.97)  than 2D 
(R
2
<0.86) [23]. These findings support the biological relevance of 3D over 2D. The 
discrepancy between 2D and 3D CT50 may be caused by differences in drug diffusion 
[24] or the effect of matrix stiffness on cell viability in response to toxins [25]. 
Consequently, 3D in vitro assays are potentially viable and accurate for screening new 
chemical compounds and are an important emerging alternative to animal testing. 
 
 
Figure 3. Correlation of CT50 values calculated from the 2D mono-layer cell culture and 3D encapsulated 
cells to reported LD50 values in rats. (A) A linear correlation between the 2D culture CT50 and LD50 values 
(R2=0.8553) (B) A linear correlation between the 3D culture CT50 and LD50 values (R2=0.9706) [23] 
 
Acrylamide (ACR) is well established as a neurotoxin, causing muscle ataxia, 
reproductive toxicity, and carcinogenic effects. The published LD50 value in rats, from 
the Environmental Protection Agency, is 159 mg/kg to 300 mg/kg (molar mass 71.08 
g/mol; equivalent to 2.237-4.221 mmol/kg) [26]. It has been theorized that ACR acts 
directly at nerve terminal sites to cause primary presynaptic dysfunction and eventual 
degeneration. Results from a study by Park et al. in 2009 indicate that ACR kills neural 
progenitor cells (the source of all neurons and glia in embryonic development) and 
impairs adult cell neurogenesis [27]. An imbalance in free radicals and reactive oxygen in 
cells was observed, leading to the conclusion that the ACR mechanism has to do with 
oxidative stress. With the neonatal mouse cerebellum cell line (C17.2) used in this 
particular study, ACR did not have a toxic effect up to 250 µM concentration. Levels 
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over 500 µM significantly decreased cell proliferation, and according to 
immunocytochemistry staining, caused apoptotic cell death [27]. High levels of ROS 
were measured, a protein involved in axon degradation and cell death. Though the 
intricacies of the cellular pathways induced by acrylamide are still not entirely 
understood, the compound is well established as an agent of apoptosis, and, due to its 
availability in our lab and relative ease of use, is a good choice of toxin for our research. 
 
1.3 Preliminary Study 
This project is based in part on a preliminary study done by two members of our team as 
a component of a Neurobiology course in the spring of 2013. We investigated the ability 
to culture and grow primary neurons in 3D hydrogel environments with varying 
mechanical properties. For this initial research, neurons were cultured in 1% and 0.25% 
alginate plus 0.5 mg/mL collagen, resulting in two distinct levels of scaffold stiffness. 
The 0.25% alginate-collagen gel was utilized because it is more closely associated with 
the stiffness of the spinal cord environment in vivo. Through cell staining and fluorescent 
microscopy, we were able to observe a clear disparity between the two experimental 
conditions; we noted an increased presence of axonal outgrowth in the 0.25% alginate 
compared to the 1% alginate condition (approximately 80% of cells exhibiting axonal 
outgrowth as opposed to 26%) and saw far greater axon length in 0.25% relative to 1% 
alginate (approximately 7 times greater in length). Further study was clearly needed to 
make the results more robust and develop the system to be more analogous to natural 
development. However, this preliminary success sparked our interest in neural culture 
and suggested there was reasonable potential in pursuing the application of primary 
neuron 3D cultures for neurotoxicity screening. See Appendix A for complete data from 
the preliminary study. 
 
1.4 Significance 
Every year, five million Americans are diagnosed with one of 600 neurodegenerative 
disorders, but the exact causes of many of these nervous system diseases are still 
unknown, and drug treatments are frequently inadequate [28]. Furthermore, during 
prenatal development and early childhood the susceptibility of the developing nervous 
12 
system to toxins is heightened [21]. This presents a need for reliable methods of 
toxicology screening for pharmaceutical compounds, as well as enhanced methods to 
culture and study neurons in vitro in order to better understand their acutely complex 
functions and disease mechanisms.  
 
Within the broader field of drug development, studies have shown that the success rate of 
developing and marketing a drug in the U.S. and Europe is only eleven percent, three 
percent of which are said to be withdrawn due to previously unobserved side effects [22]. 
Considering that advances in technology have allowed for the rapid development of new 
drugs and pharmaceutical compounds, equally advanced  toxicology testing is direly 
needed to ensure that products are safe and able to be brought economically to market 
and ultimately to patients in need. 
 
Current in vitro methods for toxicity testing do not match the physiological responses 
observed in vivo. Consequently, animal models are widely used in the stages of 
pharmaceutical development of identifying lead compounds and selecting for safe 
candidates. Depending on the type of drug and scale of production of the company, 80 to 
800 animals are needed for testing a drug, contributing to the average cost range of $950 
million to $6 billion per drug [29, 30]. Animal testing is costly, is time-intensive, raises 
ethical concerns, and even then does not reliably reflect human toxicity effects.  
 
In the future, a standardized three-dimensional (3D) culture system such as the platform 
investigated in this project will help overcome these barriers and challenges in 
pharmaceutical development and neurotoxicity research. Toxicity studies performed in 
3D have been found to better correlate to real responses to toxins in the body than those 
in 2D do; these findings encourage 3D systems as a promising avenue for replacing 
animal testing [23]. The 3D system investigated here could be adapted as a high 
throughput system, precluding the use of animals in the initial stages of safety screening 
and ultimately resulting in fewer animals sacrificed and reduced time and expense for 
drugs to be developed. To that end, this project may have indirect implications in helping 
make pharmaceuticals more affordable and accessible to populations in need. 
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In response to that need, this research project began to take shape. Our team came 
together through mutual interest in biomimetic three-dimensional cell culture for 
cytotoxicity and possible therapeutic applications. We were also enthusiastic about 
working with primary cells. Primary cells are taken directly from living tissue. We 
decided to use primary neurons because although their sensitivity makes them very time-, 
labor-, and cost-intensive to work with, they are inherently biologically relevant. Primary 
cells in general are advantageous because of their wild-type, unadulterated nature, which 
translates to in vitro cultures that better preserve structural and biochemical complexity 
found in vivo.  
 
This is in comparison to immortalized cell lines that are genetically modified to facilitate 
efficient lab use, but contain unnatural mutations that reduce their ability to accurately 
represent in vivo cellular behaviors. Primary neurons from freshly dissected chick embryo 
spinal cords beget cultures with a diversity of cell types like what is seen in nervous 
tissue in the body, including glial cells, motor neurons, and interneurons. As the goal of 
the project was to mimic in vivo environments, we chose to utilize primary, naturally 
behaving neurons. We expected this would lead to meaningful, physiologically-relevant 
cytotoxicity results. 
 
1.5 Project Goals 
The overall goal of this project was to design a biomimetic three-dimensional hydrogel 
scaffold that is able to promote primary neuron maturation and axonal outgrowth as a 
system for toxicology screening. Our research plan was two-fold: the first phase was to 
develop a scaffold that exhibits similar properties to in vivo conditions for neural cells 
and is able to sustain primary neurons, and the second was to examine the effects of a 
known neurotoxin on cells in the culture system. These two major milestones correspond 
to the two modules of the project, which will be discussed in depth in chapters 5 and 6, 
respectively. We strove to fine tune a 3D system that is successful in culturing primary 
chick neurons, defined for the purposes of this project as surviving seeding at a 
significant rate and extending their axons in the scaffold. This demonstrates that the cells 
mature in a satisfactorily analogous manner to their natural behavior in the body. In order 
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to accomplish this, we varied the density of the alginate or collagen gel and the 
availability of the extracellular matrix proteins collagen, laminin, and fibronectin. 
Progress towards the goal of creating an optimized system was determined through an 
extensive set of assays, immunocytochemistry visualization, and neurotoxicity testing. 
We predict that 3D protein hydrogels will promote biomimetic cell fates, and that 
consequently the cellular response to a known neurotoxin in a 3D neuron culture will be a 
more accurate representation of the toxic response in living animals than the response in a 
2D neuron culture is. 
 
1.6 Team and Project Management 
Our three-member team most often worked together on the experimental design and 
collaborated efficiently in the lab. Occasionally, we also found it beneficial to specialize 
and divide up tasks. For example, Nicolo had experience assisting with tissue engineering 
research, so on several occasions he coordinated preparing gels or protein-coated plates. 
Jessica was the most skilled at dissection initially, so she might isolate spinal cords while 
the other group members performed other tasks. Jessica and Teresa purchased and cared 
for the eggs weekly. Communication was key to accomplishing the project, and the team 
was constantly in contact via email, the project website, and near-daily meetings. We 
created a very constructive and cooperative team dynamic in which we brainstormed 
ideas together and made sure that responsibilities were distributed equally. 
 
1.7 Resources and Funding 
Funding for this project was generously provided by the Santa Clara University School of 
Engineering ($1,500). In addition, we received donations of two sets of secondary 
antibodies from Santa Cruz Biotechnology, Inc. (valued at $101 each) and laminin and 
fibronectin protein from Life Technologies (value $231). Detailed information on the 
allocation of funding can be found in Appendix B. 
 
1.8 Project Timeline 
To overview the timeline for this project: in spring 2013 we performed preliminary 
experiments; in fall 2013 we did literature research, applied for funding, determined 
15 
materials and reagents needed, ordered or requested donations of supplies, and performed 
practice dissections; and in winter 2014 we continued literature research, carried out 
weekly experiments and data collection, and began compiling the written thesis. In spring 
2014 only a few experiments remained in order to put together a complete Senior Design 
presentation, minor additional testing was performed after the conference to gather more 
comprehensive information, and lastly the thesis and presentation were finalized. Refer to 
Appendix C for the complete Gantt chart delineating the tasks for the winter and spring 
quarters 2014, when the experimental work took place. Though we had specific goals of 
information to obtain, the exact schedule of experiments was by necessity flexible, to 
account for various challenges that arose. 
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2. Systems Level 
 
2.1 Systems Level Overview 
During January to April 2014, a series of experiments was performed to design and 
optimize a 3D culture system for neuron survival and axonal outgrowth. In addition, 
these experiments established that the system could be assayed and the cells visualized by 
reproducible methods. Before experimentation began our team laid out a tentative 
schedule, which was continuously altered as results came in and unforeseen challenges 
arose. Here is an overview of the experiments, listed in chronological order, which were 
carried out for the purpose of achieving the thesis objective. 
 
1. Varying cell density in alginate-collagen composites: This experiment sought to 
replicate previous results, seeding neurons in an alginate-collagen composite 
(0.25% alginate, 0.5 mg/ml collagen). By varying cell density (1x10
3
, 2x10
3
, 
3x10
3
, 4x10
3
, 5x10
3
, and 25x10
3
 cells per well), we looked to determine an 
appropriate seeding cell density range compatible with WST-8 cell survival 
assaying for this particular cell type. 
2. Acellular ECM protein analysis: Plates were made without cells, containing pure 
collagen, fibronectin, or laminin, with the goal of assessing the background noise 
in WST-8 assays produced from these ECM protein-alginate gels.  
3. Varying cell density and alginate stiffness: The purpose of experiment three was 
to obtain more robust data regarding the optimal seeding density (1x10
3
, 4x10
3
, 
8x10
3
, and 12x10
3
 cells per well), and to determine which of the qualitatively 
narrowed down alginate concentrations (3% or 4%) performs best for neuron 
cultures. Plates of collagen-, laminin-, and fibronectin-alginate composite gels 
were used so that this information could be gathered pertaining to each protein. 
4. ECM protein density in 2D: This experiment assessed the ability of ECM proteins 
laminin and fibronectin to promote neuron survival and axon growth alone. A 2D 
control enabled examining the chemical variables alone, without the 
dimensionality and diffusivity parameters introduced by alginate hydrogel. It was 
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also valuable for comparing the morphology of neurons grown in 2D versus 3D 
post-staining. Protein concentration varied from 10 µg/mL, 25 µg/mL, 50 µg/mL. 
5. ECM protein density in 3D: Performed concurrently with Experiment 4, this study 
also used three different protein concentrations, 10 µg/mL, 25 µg/mL, 50 µg/mL, 
but in the form of alginate composites. The goal was to determine which ECM 
protein condition best supports axon growth in three dimensions. 
6. 2D cell density and assay determination: This experiment tested cell 
concentrations of 5,000, 25,000, 50,000, 75,000, and 100,000 cells per well on 
collagen, laminin, and fibronectin coated surfaces, with the goal of comparing the 
ability of MTT and WST-8 assays to assess cell viability. 
7. Toxicity in 2D and 3D laminin, for assaying: This experiment introduced 
acrylamide toxin to neurons growing on laminin coated plates and in laminin-
alginate gels. The aim was to determine the CT50 of acrylamide on primary 
neurons and glia, using acrylamide concentrations of 0, 0.01, 0.1, 1, 10, and 100 
millimolar acrylamide. 
8. Analysis of U87 cells in 2D and 3D: This experiment used MTT and WST-8 to 
determine the viability of U87 cells, a neuroblastoma cell line, in pure collagen 
gels. The goal was to make sure that the assays worked properly on cells in 
collagen gels, with a cell type that we were familiar with and knew from previous 
experience should work.  
9. Toxicity on 2D laminin and collagen, for assaying and visualization: The goal 
here was to determine the CT50 and response to acrylamide toxin of primary 
neurons and glia cultured on collagen and laminin using WST-8 assay. Also 
included in this experiment was a preliminary test of neuron viability and 
maturation in 3D collagen gels. 
10. Toxicity in 3D collagen, for assaying: This experiment determined the CT50 to 
acrylamide in 1 mg/mL collagen gels exposed to 0, 0.01, 0.1, 1, 10, and 100 mM 
acrylamide using MTT assay. 
11. Mechanical characterization: The goal was to gather rheometric data on the 
viscoelasticity of 1 mg/mL collagen gels. 
12. Toxicity in 3D collagen, for visualization: For this experiment we seeded a lower 
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cell concentration into 8-well chamber slides, in 0.5 and 1 mg/mL collagen gels, 
and exposed them to 0, 1, 10, and 100 mM ACR. The goal was to stain and 
visualize the toxic response with immunofluorescence. 
13. Toxicity in 3D collagen, for visualization: In this experiment we used larger (200 
µL instead of 50 µL) 1 and 2 mg/mL collagen gels, and stained for visualization. 
We wanted to be able to observe the effect of acrylamide on healthy, extended 
neurons. 
14. Toxicity in 3D collagen, for assaying: Here we cultured neurons in 0.5, 1, and 2 
mg/mL collagen and exposed to  0, 0.01, 0.1, 1, 10, and 100 mM ACR, with the 
goal of determining the CT50 in varying physical conditions. 
15. Mechanical characterization: Rheometric data was gathered on 1 and 2 mg/mL 
collagen, gelled in situ and ex situ. 
 
2.2 Systems Level Constraints 
A significant constraint involved in this research is the difficulty associated with the 
acquisition and isolation of primary neurons. A successful microdissection and 
dissociation of a spinal cord results in a mixed population of neurons and glia. 
Microdissection is an intricate and time consuming process, and could still result in 
unwanted populations of cells in the dissociated culture. For this experiment, purification 
of cell populations was not performed due to the complexity of performing the 
purification procedures. Therefore, a key constraint would be the assumption that the 
percentage of non-neuronal cells is negligible. 
  
A large number of chick embryos needed to be dissected in order to obtain enough cells 
for a single experiment. Dissecting up to a dozen embryos at a time is very time and labor 
intensive. Selection of embryos between Hamburger and Hamilton stages 25-30 resulted 
in embryos being discarded for being under or overdeveloped. Controlling embryonic 
development necessitated the purchase of fresh fertilized eggs at a specific time (7 days 
for this research) prior to the experiment. The need for many embryos and the time 
needed to progress embryonic development in eggs required meticulous scheduling and 
planning as well as obtaining a large amount of eggs.  
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An added constraint is the batch-to-batch variability that is involved with using multiple 
embryos. Each embryo is a distinct organism, and thus is not genetically identical to 
another. It is an assumption that these differences are negligible and not significant 
enough to affect the response to neurotoxin. Furthermore, every brand of fertilized eggs 
may come from a different species of chicken thereby increasing the chances of 
variability. In order to mitigate this issue, eggs were generally purchased from the same 
brand and supplier. However, a change was made in source of eggs from Trader Joe’s to 
Whole Foods since the latter had a steadier supply of fertilized eggs. An additional issue 
was the regularity of deliveries which was not consistent throughout the course of the 
experiments. In general, eggs were purchased based on the most recent Julian date, which 
ranged from one to seven days post-packaging. Furthermore, the post-packaging storage 
of the eggs was not clearly identified so refrigeration at less than optimal temperatures 
may have been involved prior to their purchase. This would result in some variations in 
the development of some eggs between experiments. This issue was dealt with by 
familiarization of delivery patterns at the source as well as careful selection of eggs prior 
to dissection. Overall, the discrepancies in Julian date and unknown post-packaging 
storage was not a big problem, and did not yield large quantities of non-viable embryos. 
  
The inability of neurons to proliferate was another constraint to the project. In contrast, 
glial cells, which are mixed in with the population of cells cultured in the system, 
proliferate; this presents the problem of long term cultures being dominated by glia. 
While neurons remain at a constant amount until cell death, glia will continuously divide 
and increase in population. For the purposes of this research, short term cultures were 
employed with the assumption that the glial amount is not significant enough to skew cell 
viability and cytotoxicity data and that neurons can survive in vitro for short periods of 
time. Future experiments would need to take glial proliferation into account to increase 
the robustness of the assay. 
  
The use of chick embryos as the source of primary neurons for this research presents its 
own constraint. Since the goal of the project was to provide a neurotoxicity assay that 
would be of relevance to early drug candidate identification, the choice of using neurons 
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from chicks and not humans would inherently reduce the biological relevance of the 
system. While chicks provide a representative model for other animal tissues, especially 
at such an early developmental stage, if this system is intended for preliminary testing of 
pharmaceuticals intended for human use the substitution of human-derived neurons 
would provide a more biologically relevant system. However, the success of using chick 
embryo-derived neurons in this culture system has value as a proof-of-concept and a 
starting point prior to the study of other cell sources. 
  
Lastly, this particular system cannot be easily implemented in a high-throughput manner. 
This present constraint prevents its practical use in an industrial setting where most drug 
development occurs. The micro-dissection and harvesting of neurons from chick embryos 
is time consuming and is not an automated procedure. Furthermore, the study of axon 
retraction, within the scope of this research, is presently qualitative; therefore, it may 
presently not be a valid output for neurotoxicity screening. Improving methods for 
viewing and analyzing axonal outgrowth in a manner that is more compatible with high-
throughput screening is outside the scope of this research. With further refinement, this 
system could evolve into a robust neurotoxicity screen capable of processing higher 
amounts of samples. 
 
2.3 Engineering Standards 
In engineering, health and safety is a preeminent concern that refers to making a product 
that is completely non-harmful to consumers. In the context of this project, we are aiming 
to design a method that would help pharmaceutical companies produce medications that 
are safer for consumers. As mentioned earlier, only a small percentage of 
pharmaceuticals make it to market, and a significant number of those are recalled. Drugs 
are recalled after someone has reported a negative side effect or serious problem. We 
would like our system to be a more accurate screen for the toxic effects of pharmaceutical 
candidates, and reduce the amount of suffering due to unforeseen negative side effects.    
 
In addition to producing safer medications, our project would potentially reduce the 
manufacturing cost of those medications for the company, thereby benefiting the 
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company economically. As mentioned in the previous chapter, up to 800 animals are used 
while characterizing and ensuring the safety of drug candidates. Animal testing is 
necessary for developing safe pharmaceuticals for human use, but is very expensive, 
frequently ineffective, and morally troublesome to many people. We would like our high 
throughput in vitro system to take the place of animal testing, or at least significantly 
reduce the quantity of animals needed. This has positive economic and ethical outcomes.  
 
Reducing the overall cost of manufacturing would decrease the cost of the final product 
for the consumer. More affordable medications could benefit consumers locally and 
globally. Within our own society, many people struggle to purchase necessary 
medications due to the high cost. Improving the efficiency of drug development will 
translate into benefits for not just pharmaceutical companies but the larger community. 
Bringing down the costs of development will potentially increase availability and 
accessibility of crucial products, especially for lower-income people and populations in 
developing countries. 
 
Another ethical issue we confronted as conscientious engineers was using chick embryos 
as a cell source. We only used chicks that were in embryonic day six of development, and 
were between stages 25 and 30 on the Hamburger and Hamilton stage chart. We used 
these chicks because neurons in the CNS have not connected to their targets within the 
body yet. This means that the brain is not connected to any part of the body, so the chick 
has no sensory input—it does not feel pain. Additionally, we felt ethically justified in 
using the chicks that we did because if the eggs had not been incubated, they would have 
ended up being consumed as food. We bought our eggs straight off the shelf at Whole 
Foods, which means we simply repurposed eggs that were not going to become animals 
from being food to being our cell source.  
 
Furthermore, using embryonic chick cells in an in vitro testing system is still reducing 
animal testing, because they take the place of large numbers of live animal models. We 
acknowledge that we are using animals, but we are using far fewer that are employed 
when traditional methods are used. On average, we could use cells derived from five to 
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seven embryos to test six drug concentrations, in triplicate, in three different 
concentrations of collagen—a total of 54 samples. Using in vivo methods, this experiment 
would have required 54 individual adult rats or other laboratory animals. We are still 
using animals, because we believe primary cells are more accurate for modeling, but we 
are using far fewer animals than traditional testing methods.  
 
2.4 Design Approach 
Our project is unique because culturing primary neurons has not been attempted by 
bioengineering students for a Senior Design Project at Santa Clara University and is a 
new undertaking for our advisors as well. This presented some significant hurdles getting 
started and more challenges along the way. Our experimental approach was to start with 
an idea, carry out literature research, and present our advisors with a proposed 
experiment and protocol. Literature research is the foundation of our experimental 
design. We heavily researched studies that worked with our materials of interest and 
adapted published protocols to fit our needs. Additionally, since this is a novel Senior 
Design Project, our advisors were a tremendous resource because of their knowledge of 
the field and of how to approach research. Our advisors have provided invaluable 
guidance by suggesting methods of experimental set-up and input based on emerging 
results. 
 
Our project has required us to adapt quickly to unexpected circumstances and results. We 
formulated a detailed tentative schedule of experiments for the winter quarter, and we 
were continuously forced to deviate from it. In the beginning, our assay results were 
inconclusive, so we had to troubleshoot our materials and methods. The schedule of 
experiments was ever-changing to accommodate the previous results. We responded to 
troubling results by again consulting the literature and our advisors. A solution would be 
drawn up after finding an alternative protocol in another research paper, and we would 
meet with our advisors to discuss the possibility of changing our methods or experimental 
design. Details of specific challenges that arose and how we responded to them will be 
discussed further on in sections 5.2 and 6.2. 
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3. Systems Set Up 
 
3.1 Embryo Dissection 
Chicken eggs were obtained from Trader Joe’s grocery store for Experiment 1, and for all 
the following experiments Rock Island fertile eggs from Sonoma County, CA, were 
purchased from Whole Foods Market. Eggs were picked up early in the morning, and 
only selected if the Julian date code read that the carton had been packaged within seven 
days prior—the freshest eggs possible were always preferred. Eggs were then transported 
to the lab, allowed to acclimate to room temperature for 3-5 hours, and then incubated at 
37°C for seven days. To begin the dissection, embryos were excised from the eggs and 
examined to determine their developmental stage (Table 2).  
 
Table 2. Developmental stage of embryos dissected. If the total number of embryos indicated in the third 
column exceeds the number in the second column, it means that fractions of spinal cords were extracted 
from multiple embryos (i.e. for Experiments 1 & 2, three full spinal cords and two half spinal cords were  
harvested, from five total embryos). 
Experiment number Total amount of spinal 
cords isolated 
Developmental stage of the dissected embryos 
1 & 2 4 25-26, 27, 25-26, 26-27, 25 
3 5.75 25-26, 25, 25-26, 27-28, 26, 27, 28-29 
4 & 5 4 26, 25-26, 27, 26-27 
6 5 28, 26, 28, 27-28, 27-28 
7 4.5 26-27, 27, 26-27, 26, 27 
9 5.75 25, 27, 26-27, 26-27, 27-28, 27, 27-28 
10 5 27, 29, 29, 27, 28, 28, 28 
12 4.25 26, 27, 26, 28, 28 
13 6.75 26-27, 26-27, 27, 26-27, 26, 28-29, 28 
14 12.25 27, 26, 27, 26, 25, 27, 27, 27-28, 28, 26-27, 28, 
28, 28 
   
 Average development stage: 26.9 
 
The 45 developmental stages of chick embryos were defined by Hamburger and 
Hamilton in 1951. For the purposes of this project, spinal cords were isolated from 
embryos in stages 25-30, shown in Figure 4 below. At this level of embryonic 
development, interneurons have established preliminary axons within the spinal cord, but 
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motor neurons have not yet made contact with their target muscle cells outside the spinal 
cord.  
 
 
Figure 4. Hamburger and Hamilton’s stages 22-33 in the development of the chick embryo [6] 
 
Dorsal root ganglia (DRG) tissue was removed from the spinal cords as much as possible. 
DRGs are clusters of glial cells and afferent sensory neuron cell bodies attached to the 
exterior of the developing spinal cord along its length, at the interface of the central and 
peripheral nervous systems. Each week, the ratio of fertilized to unfertilized eggs was 
recorded to ensure the feasibility of the source for regular experimentation (Table 3). The 
complete dissection protocol is provided in Appendix D. 
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Table 3. Egg supply information and fertilization rate 
Source 
Julian 
date 
Purchase 
date 
Dissection 
date 
Number of 
eggs 
purchased 
Number of 
eggs 
incubatedᶧ 
Number 
of dudsᶧᶧ 
Fertilizatio
n rate 
Trader Joe’s 007 01/10/13 01/17/14 36 36 8 78% 
Whole Foods- 
Rock Island 016 01/17/14 01/24/14 36 34 4 88% 
Whole Foods- 
Rock Island 020 01/24/14 01/31/14 36 32 1 97% 
Whole Foods- 
Rock Island 029 01/31/14 02/07/14 24 24 0 100% 
Whole Foods- 
Rock Island 034 02/07/14 02/14/14 24 24 1 96% 
Whole Foods- 
Rock Island 041 02/14/14 02/21/14 24 24 12 50% 
Whole Foods- 
Rock Island 048 02/21/14 02/28/14 24 24 3 86% 
Whole Foods- 
Rock Island 055 02/28/14 03/07/14 24 24 0 100% 
Whole Foods- 
Rock Island 085 04/02/14 04/09/14 24 24 0 100% 
Whole Foods- 
Rock Island 091 04/09/14 04/16/14 12 12 0 100% 
        
      
Average 
fertilizatio
n rate: 89.5% 
ᶧ Eggs were thoroughly inspected before being put in the incubator and any with cracks discarded 
ᶧᶧ Eggs that did not contain an embryo were recorded as “duds”. Fertilization rate was calculated as follows: 
[(Number of eggs incubated - Number of duds) / (Number of eggs incubated)] x 100 
 
3.2 Spinal Cord Dissociation 
Once the spinal cords were isolated, they were enzymatically dissociated using trypsin, a 
protease which catalyzes the hydrolysis of peptide bonds and degrades intercellular 
connections. A single cell suspension can then be generated. Details of the dissociation 
protocol can be found in Appendix D. Because dissection and plating were performed in 
different lab spaces for many of the experiments, the isolated cells were safely and 
securely transported on ice before counting, dilution, and seeding. 
 
3.3 Gel Preparation and Cell Seeding 
For three-dimensional experiments, neurons were suspended in alginate-composite or 
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pure collagen hydrogels in 96-well round bottom plates. The cell density was determined 
by hemocytometer; then the cells were diluted in NeuroBasal culture media containing 
1% Penicillin-Streptomycin-Glutamine and B27, from Life Technologies. In Experiment 
6, because of concerns about the fraction of cells that were alive from dissociation and 
successfully attaching to the substrate in 2D controls, Trypan Blue exclusion was used 
while counting. Trypan Blue is an impermeable dye that is taken up by dead cells, 
causing them to appear blue under the viewing microscope. By mixing a 1:10 dilution of 
Trypan Blue (Life Technologies 15250-061) with a small aliquot of cell solution to be 
counted in the hemocytometer, the concentration of viable cells alone can be determined. 
Low viscosity brown algae-derived sodium alginate was purchased from Sigma Aldrich 
(catalog number A1112). To cross-link and functionalize the alginate gels, 100 mM 
CaCl2 was applied for approximately 10 minutes. Pure collagen gels were functionalized 
by pH neutralization using 1M NaOH concurrently with temperature increase from on-ice 
to 37°C . Depending on the specific experiment, ECM proteins were also suspended in 
the gels. Rat tail type I collagen protein, natural mouse laminin protein, and bovine 
plasma fibronectin protein were obtained from Life Technologies (catalog numbers 
A1048301, 23017-015, 33010-018). 
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4. Systems Integration and Testing 
 
4.1 Cell Viability and Toxicity Assays 
For these experiments, two methods of cell viability were used for testing: 2-(2-methoxy-
4-nitrophenyl)-3-(4-nitrophenyl)-5-(2,4-disulfophenyl)-2H-tetrazolium, monosodium 
salt, WST-8 (Dojindo Cell Counting Kit-8) and  3-(4,5-dimethylthiazolyl-2)-2,5-
diphenyltetrazolium bromide, MTT (ATCC Bioproducts MTT Cell Proliferation Assay) 
[31,32]. MTT and WST-8 are tetrazolium salt variants which produce insoluble and 
soluble formazan dyes, respectively [33, 34, 35]. These tetrazolium salts are useful as a 
measure for cell viability in culture since these salts are reduced upon exposure to living, 
metabolically active cells expressing dehydrogenase enzymes [31, 33]. When reduced, 
tetrazolium salts produce a colored formazan dye, which has seen increased application 
in cell viability assays over recent decades [35]. Typically, tetrazolium salts are cationic 
and thus are water-soluble with the exception of MTT [35]. MTT results in a neutral 
formazan product thereby making it insoluble in water, making it possible to locate sites 
of increased enzyme activity; however, the insoluble dye necessitates an extra step since 
formazan needs to be solubilized first [33,35]. 
 
4.1.1 Data Acquisition and Analysis 
The resulting dyes solubilized in our well plates provide a colorimetric assay, which we 
can then measure using a spectrophotometer. Spectrophotometric readings were taken 
using a Tecan Infinite M200 Pro plate reader; WST-8 absorbance was measured at an 
excitation wavelength of 450 nm while MTT was taken at 570 nm. The resulting raw data 
has units we have arbitrarily called relative fluorescence units (RFU), as they are the 
fluorescence readings at a particular absorbance. Data analysis was performed using 
Microsoft Excel.  
 
Viability statistics were double normalized according to their experimental parameters. 
For example, in cytotoxicity tests, the average absorbance readings were taken as a 
percentage out of the average of the no-toxin control plus the lowest toxin concentration 
absorbance readings. These are done with the assumption that these two conditions 
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represent wells where there was maximum cell survival. The second normalization is 
calculated by subtracting each primarily normalized value and by the minimum value of 
the set and dividing the difference by the range. This normalization would yield a set of 
values between 0 and 1, which may be interpreted by as a percentage of cell survival. 
 
Determination of CT50 was done by graphing the double normalized cell survival data 
and using a linear regression on the two points on either end of the fifty percent survival. 
This value is only an approximation of CT50 given the lack of access to appropriate 
statistical analysis software. 
 
4.2 Immunocytochemistry 
Immunocytochemistry (ICC), an antibody based cell staining technique, was the method 
used to visualize the cells that were exposed to toxins. ICC involves the utilization of an 
antibody that selectively binds to a specific protein and a second antibody that binds to 
the first one and serves as a fluorescent marker [36, 37]. Primary mouse E/C8 
monoclonal IgM antibody (Developmental Studies Hybridoma Bank) was used to stain 
the neuron cultures; secondary antibodies were fluorescein-conjugated goat anti-mouse 
IgM (Santa Cruz Biotechnology, Inc.). The antigen for E/C8 is a particular neurofilament 
protein that is specific to embryonic avian species. It is called NAPA-73 and has been 
identified as a 73 kDa intermediate filament-associated protein [38]. Neurofilaments are 
specialized structural assemblies of intermediate filaments found only in neurons. 
Immunofluorescence staining reveals that neurofilament is located in the cell body and 
longitudinally along the axon fibers [38]. E/C8 tends to be a relatively vibrant antibody, 
and was therefore an appropriate neuron-specific marker to use to visualize primary 
neurons in two and three dimensions. Prior to immunostaining, cultures first need to be 
treated with a fixative that would preserve the environment within the hydrogel and make 
it amenable for staining [36]. The fixative used for these experiments is 4% 
paraformaldehyde (PFA). See Appendices E and F for the complete 
immunocytochemistry fixing and staining protocols used. 
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4.3 Microscopy 
Non-stained cells were viewed under a Leica Fluorescence Microscope with camera. 
Antibody-stained cells were visualized using a Zeiss Axioskop fluorescence microscope, 
with a Cooke SensiCam QE High Performance camera and Image Pro Plus software. 
Each well was methodically scanned column-wise to overview the sample. 
Representative images were taken of neurons with a Zeiss 40x magnification objective to 
reflect their growth patterns in that particular condition. In order to process the images in 
Adobe Photoshop, two images were taken of the same neuron using the two different 
fluorescent filters to visualize both the DAPI stain and the neurofilament stain. The 
microscope filters enabled viewing fluorescein, which is excited by 488 nm light and 
emits at 530 nm (green color), and DAPI, which is excited by 358 nm light and emits at 
461 nm (blue color). These were saved as RGB24 files. The neurofilament files were also 
saved as 8-bit grayscale images to be used with NeuronJ software for axonal outgrowth 
quantification, discussed next.  
 
4.4 Quantifying Axonal Outgrowth 
An open source program called ImageJ, with its plugin NeuronJ, was used to trace and 
quantify neurite lengths from the images of ICC stained plates [39]. Using this program 
to collect data regarding neurite length enables standardized, consistent measurement.  
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5. Module One: Establishing 3D Culture Parameters 
 
5.1 Introduction 
In order to come up with the proposed 3D hydrogel culture system, several parameters 
first needed to be determined. The first was an appropriate cell concentration that would 
result in a signal for cell viability assays. Second, a single cell viability assay would also 
need to be chosen based on its ability to give a consistent signal. Next, tests were 
conducted to assess various ECM proteins for their ability to form neuronal attachment 
points. Lastly, hydrogel density characterized by alginate concentration needed to be 
selected. Cell seeding density is an important parameter for reliable viability assay data 
and for the health of cultures. Hyperconfluent cultures could result in cell death due to 
physical crowding and nutrient competition. Hypoconfluent cultures, on the other hand, 
would not result in a clear signal for spectrophotometric analysis needed in the cell 
viability assays. The specific assay to be used in the system must be chosen according to 
which would result in the most reliable, consistent, and clear signal for the particular cell 
type, seeding concentration, and culture environment. ECM protein selection is important 
as it governs the survival of neurons as well as axon growth within the hydrogel. 
Furthermore, homogenous ECM protein integration into the hydrogel was an important 
parameter that came up during hydrogel selection. Lastly, concentration of hydrogel 
components, specifically of alginate and collagen, determines the stiffness of the cellular 
environment. In order to attain the goal of biological relevance, stiffness should ideally 
correlate with the cell’s native tissue.  
 
5.2 Key Constraints 
We found in the early experiments with alginate-protein composites that either the ECM 
proteins or the alginate interfered with WST-8 assay. There was very high background 
noise in control conditions. We thereafter made sure to include a comprehensive set of 
controls, and proceeded by sorting out one parameter at a time: first the optimal cell 
density, then alginate concentration, then the protein composition. 
 
Another major issue quickly arose: in Experiments 1 and 2 we were unable to generate 
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alginate hydrogels that were consistently mechanically stable. We concluded that this had 
to do with the brand of low-viscosity alginate which we were using, which was different 
from the type in the bioengineering lab that we were familiar with using before. This 
previous type of alginate that behaved consistently, however, it was discontinued by the 
manufacturer, so we had decided to buy a different one in order to have a reproducible 
protocol. To deal with the issue of unexpectedly soft, watery alginate gels, we set up a 
qualitative comparison with the “old” alginate. We made up six different concentrations 
of our new alginate, 6%, 5%, 4%, 3%, 2%, and 1%, and compared their stiffnesses to 
0.25% and 1% gels of the old alginate by manually poking them. This helped to get a 
sense of the stiffness profile of the new type of alginate relative to the previous type that 
we were familiar with. 
 
Nevertheless, in Experiments 3-7 alginate composites assayed with WST-8 and MTT did 
not produce very consistent or robust data. After discussion with our advisors, we 
decided that the data in 2D from this period was most useful, and to move into using pure 
collagen gels as an alternative to alginate. Collagen for 3D cell culture is well established, 
and our advisor Dr. Sabatier has extensive experience working with primary neurons in 
collagen. To confirm that collagen would work with the viability assays more 
consistently that alginate did, we ran Experiment 8, “Analysis of U87 cells in 2D and 
3D”, with U87 cells on/in collagen. Running the MTT and WST-8 assays on U87 cell 
cultures, which we were familiar with working with and know are compatible, ensures 
that any confusing results we notice with primary neurons in collagen will be due to the 
nuances of the cell type and not an adverse interaction between the hydrogel and the 
assay. 
 
Additionally, the tetrazolium salts produced by the assays may not completely diffuse 
throughout the gel, thereby limiting the accuracy of the reading. Alginate pore sizes are 
variable, which would produce random dispersal patterns of the resulting salts. This could 
lead to clumping of material, which would alter the absorbance reading.  
 
Lastly, it is difficult to to visually assess axon growth in 3D alginate-composite gels. 
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Under a light microscope, the gels looked cloudy, which limited visualization of the cells. 
Before assaying the samples, there was no way to quickly check that the cells in each 
sample actually grew. Therefore, it was unclear whether it was the assay or lack of cells 
or another factor that was producing inconsistent results.  
 
5.3 Design Description 
This particular phase of the research project involved an especially dynamic approach to 
experimental design. This thereby affected the design of experiments because between 
each experiment, the group needed to analyze the previous experiment’s results prior to 
planning and executing the next one. As a result, multiple components were being studied 
across different experiments and subsequent experiments contained troubleshooting 
alterations to obtain better numbers. Consequently, certain details of experimental design 
aspects are deferred to the results and discussion section. 
 
Due to the similarities and complexity across multiple experiments, each experiment is 
left unnamed and are addressed by number. Readers are urged to refer to section 2.1 
which contains a brief summary of each experiment including their purpose. 
Furthermore, this subsection is meant to serve as an introduction to the design approach. 
This module may be summarized and categorized into the components of the system that 
were selected to obtain a viable three-dimensional scaffold and testing method. These 
components include cell concentration, hydrogel composition, and cell viability assay. 
 
5.3.1 Cell concentration determination 
An appropriate cell density was one of the first components finalized. Determination of a 
viable cell density concentration consisted of experiments where an array of varying cell 
densities were tested against a cell viability assay. The concentration at which a clear 
signal could be consistently obtained was chosen for use in subsequent experiments. As 
mentioned in the Systems Level Constraints section, the inability of neurons to proliferate 
required a higher cell count compared to a proliferating cell line. Initial experiments were 
run with relatively low cell counts, which yielded a signal, but was later deemed too 
unreliable. An appropriate cell density was determined in Experiment 6, “2D cell density 
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and assay determination”, based on our project advisors’ suggestion to significantly 
increase cell count to obtain more reliable data. 
 
5.3.2 Hydrogel component selection 
Three ECM proteins were chosen to serve as the attachment proteins for use in the 
scaffold: laminin, collagen, and fibronectin. The first module involved assessing which 
protein yielded better survival and axonal outgrowth. Initially, these proteins were mixed 
with alginate, which served as the base component that provided hydrogel stability. 
Alginate-based hydrogels mixed with collagen were the starting point for initial 
experiments. This comes from preliminary studies performed which indicated that 
alginate solution when mixed with collagen protein formed a gel conducive to neuron 
maturation and axon growth. Alginate, as described previously, is a desirable biomaterial 
that is biologically inert and is capable of forming a hydrogel whose mechanical 
properties may be tuned. By itself, collagen  is able to form its own hydrogel, and was the 
protein of choice in preliminary studies. Laminin and fibronectin were tested since they 
would increase biological relevance since laminin is found in abundance in CNS tissue. 
Experiments intended to help choose the appropriate protein were conducted throughout 
the entire module. These experiments used a mix of cell viability assays to determine 
which protein conferred the best environment for survival. Concurrently, visualization 
through a light microscope was used to assess axon length qualitatively in 2D and 3D 
gels. 
 
5.3.3 Choice of cell viability assay 
Experiments for this first module used two different cell viability assays: MTT and WST-
8. WST-8 was initially favored due to the fact that it is less time-intensive relative to 
MTT and the manufacturer advertised it as being more sensitive than most other assays, 
including MTT [32]. Most early experiments were run with the WST-8 assay, but signals 
in 3D hydrogels of alginate-composite and collagen gels were less than ideal. This 
prompted comparative testing between the two assays to determine which would be most 
appropriate for the system. In general, testing of cell viability assays involved 
determining which gave a stronger signal for the particular hydrogel system. 
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5.4 Results and Discussion 
5.4.1 Cell concentration 
The experiments in this module provided us with an initial understanding of how primary 
neurons behave in 3D in vitro culture, and an idea of what parameters to implement 
moving forward into toxicity screening assays. MTT and WST-8 cell viability assays 
performed with varying neuron concentrations indicated that the cell seeding density at 
75,000 cells per well was most suitable for assaying purposes. These results are seen 
below in Figure 5. 
 
    
          a                  b 
Figure 5. Cell viability determined using (a) MTT assay and (b) WST-8 assay of 2D primary neuron 
cultures, on plates coated with 0.5 mg/mL collagen. Obtained in Experiment 6. 
 
For an early experiment we used cell concentration of 25,000 cells per well, and obtained 
meaningless results from WST-8 assay (data not shown). By next performing the assay 
on a gradient of cell concentrations, seen in Figure 5, we show that that cell concentration 
was much too low to generate a signal that is distinguishable from the no-cell control, and 
a higher concentration in the range of 75,000 to 100,000 cells per well is more 
appropriate. We observed these cultures that were optimized for assaying under the 
viewing microscope and decided that a much lower density of 20,000 cells per well 
would be ideal for visibility, so that individual cells and their axons can be distinguished.  
 
5.4.2 Hydrogel component selection 
Alginate composite gels with laminin and fibronectin ECM protein were initially tested 
alongside collagen, and the relative fluorescence units measured in MTT and WST-8 
assays were similar to collagen (data not shown). We also observed ample axon 
35 
extensions on 2D plates coated with laminin and fibronectin, so these proteins are 
encouraging future options to try to incorporate into the culture system. The alginate 
composite gels, however, did not yield clear signal when assayed with WST-8 and MTT, 
and produced several rounds of inconsistent results. Based on qualitative observations of 
alginate composites with varying ECM proteins, we determined that there was a lot of 
difficulty in observing any axon extensions when viewed under a light microscope. 
Because of the unreliability of the alginate data and the advantage of better visualization 
in pure collagen, pure collagen hydrogels were selected for moving forward with 
experiments in the second module. 
 
5.4.3 Viability assay 
MTT assays were ultimately chosen for use in the next phase of experiments, which are 
discussed in the following module. The relative fluorescence signals from MTT were 
most clear with collagen gels as the primary hydrogel component. Furthermore, their 
improved ability to obtain a reading in a 3D environment to compared WST-8 was an 
important factor for this research. This decision was reached by process of elimination 
since WST-8 was unable to produce a clear signal in 3D hydrogels as it had been in a 2D 
environment. This lack of signal is shown in Figure 6, which shows that the difference in 
RFU units between gels with cells versus control gels without cells (approximately 0.2 
RFU) was insignificant and unreliable. 
 
               + cells              - cells 
Figure 6. WST-8 signal in 1.5 mg/mL 3D collagen gels. Experimental condition seeded with primary 
neurons, control condition without cells. Obtained in Experiment 9. 
 
Experiments were performed on an alternative system using a glioblastoma cell line, 
U87s, and pure collagen hydrogels, which had previously been proven to work in our lab. 
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U87s are a glioblastoma cell line. Figure 7 reveals that the MTT and WST-8 assays are 
both able to confer signals for this system. However, given that there was an issue of 
WST-8 signal for the primary neuron system in pure collagen gels, MTT assay was the 
alternative choice. 
 
    
           2D    3D            2D               3D 
                    a           b 
Figure 7. Cell viability of U87 cells in 2D versus 3D using (a) MTT assay and (b) WST-8 assay. 2D plates 
were coated with 1 mg/mL collagen and 3D condition was 1 mg/mL pure collagen hydrogel. Obtained in 
Experiment 8. 
 
A proof of concept for the validity of MTT assay for our system is shown through a 
preliminary toxicity assay exposing ACR to 3D collagen hydrogels. As shown in Figure 8 
below, a cytotoxicity curve indicates that the MTT assay provided a gradient of survival 
when exposed to neurotoxin. Furthermore, the raw data (not shown) reported a reliable 
signal when subtracting the RFU from the wells without toxin added from the ones with 
the highest toxin level. This analysis provides the comparison between a condition with 
maximum growth and another with assumed complete cell death. This success indicated 
that primary neurons cultured in pure collagen gels could be assayed using MTT. 
 
Figure 8. Toxicity in 3D collagen assayed with MTT. 3D collagen hydrogels containing 1 mg/mL collagen 
were exposed to a gradient of ACR toxin between 0 to 100 mM. Obtained in Experiment 10. 
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5.4.4 Transition to next module 
To reiterate the goals of the first module of the project, we needed to establish a neuronal 
cell concentration, hydrogel material, and appropriate cell viability assay. We decided to 
use 75,000 cells per well for assaying, as this level generated recognizable signal. 
Inconsistent results with alginate composite hydrogels led to collagen as the best 
hydrogel option for neuron culture at this time. Lastly, MTT assay was selected to use 
with 3D collagen cultures for the next experiments, in which we applied this set up as a 
platform for assessing toxicity. 
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6. Module Two: Assaying and Visualizing Response to Toxin 
 
6.1 Introduction 
The second phase of the project involved testing the system’s capability to serve as an 
assay that provides cytotoxicity data and is ability to detect the effects of neurotoxin on 
neuronal maturation via axon outgrowth and retraction. This set of testing aimed to 
determine whether neurotoxin affects cells in our system in a manner that is comparable 
to in vivo models or other previous in vitro work. Comparable results allow the 
conclusion to be made that our system is effective in assessing the neurotoxic properties 
of chemical compounds. As determined from the first set of experiments in the previous 
chapter, collagen was selected for use at concentrations of 0.5 mg/mL, 1 mg/mL and 2 
mg/mL for cytotoxicity assaying and 1 mg/mL and 2 mg/mL for visualization of axon 
retraction. Seeding density would be set at 75,000 cells per well for assaying and 20,000 
cells per chamber for visualization. Lastly, MTT was deemed the more appropriate 
viability assay for subsequent testing. These parameters provided consistent culture 
conditions, which were then verified with assays and manual visualization techniques. 
 
6.2 Key Constraints 
A major obstacle occurs during the process of immunocytochemistry; specifically, the 
fixation step preceding the addition of antibodies to the hydrogel cultures. The fixation 
step involves the use of the toxic compound, paraformaldehyde (PFA), which “freezes” 
the culture by non-specifically and covalently cross-linking all proteins. The use of PFA 
necessitated multiple washing cycles to remove it from the culture. Furthermore, 
additional washes which lasted an hour each were performed after the application of each 
antibody to remove excess antibodies that did not bind to their target molecules in the 
sample. However, the process of adding and removing the washing solution multiple 
times resulted in some gels losing structural integrity. This is due to the intricacy and 
difficulty involved in order to avoid disturbing the gel during the washing process. These 
issues were more prominent in the less dense 1 mg/mL collagen hydrogels than in the 2 
mg/mL hydrogels. 
 
39 
Another constraint came with the difficulty in completely washing away the stains and 
antibodies that did not bind. While antibodies provide an accurate method for viewing the 
neurons’ nuclei and axonal neurofilaments, the three-dimensional nature of the hydrogels 
trapped a large amount of excess DAPI and primary and secondary antibodies. This 
resulted in background noise issues and hazy images when cultures were viewed under a 
fluorescence microscope. Noise was present in most images, but the overall signal of the 
desired targets was still strong enough to analyze. This issue was anticipated and 
prepared for with washing protocols designed to involve extended washing cycles and the 
placement of their chamber slide housing on a rocker. This would ensure that the washing 
solution was thoroughly mixed and thus dilute and wash away the excess compounds. 
However, as the resulting images were still characterized by background noise, longer 
washes or lower concentrations of antibody are necessary. 
  
In addition to the issue of background noise, at the time these experiments were 
conducted, the lab had no access to a confocal microscope. This limited visual analysis to 
a fluorescence microscope designed for two-dimensional slides. In order to address this 
issue, 8-well chamber slides were used to provide a system which could house the 
hydrogel in three dimensions. The  chamber walls of the slides can be removed to expose 
the 3D gels for mounting and viewing. Furthermore, the viewing of a 3D environment 
using a 2D scope resulted in difficulty in finding a focal plane wherein multiple neurons 
were in focus, since they grew in the z-plane as well. 
 
Lastly, another constraint was determining the best method for collecting qualitative data 
from fluorescence microscope images. When analyzing the stained 3D cultures, there is 
subjectivity involved in counting cells and deciding what is a cell or what may be debris 
or noise. This is made more challenging by the fact that cells are found in multiple focal 
planes and what appear to be background noise may be a cell that is out of focus. To 
avoid inaccuracy, images were taken at five defined positions and for each image the 
group reached a consensus with regard to cell and axon identification. 
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6.3 Design Description 
For this phase of the project, we adapted and simplified a version of the biomimetic 
hydrogels discussed in Chapter 5. These experiments may be divided into two parts: first, 
the testing of the system’s ability to generate a CT50 value upon toxin exposure, and 
second, the system’s ability to induce neuron maturation and subsequently be a viable 
platform for the study of neurotoxic response through axon outgrowth and retraction. 
  
6.3.1 Viability and cytotoxicity 
The first step in assessing our culture system involved the determination of CT50 of this 
particular cell population in response to acrylamide. These tests were done in both 2D 
and 3D environments, with the latter being the implementation of the biomimetic scaffold 
being developed. For 2D, 96-well flat bottomed plates were coated with 1 mg/mL 
collagen which was allowed to bind to the plate surface prior to cell seeding. For 3D, a 
mixture of cell solution and neutralized collagen solution were pipetted into 96-well U-
bottomed plates, with collagen concentration set at 0.5, 1, and 2 mg/mL. Seeding density 
used was 75,000 cells per well, or 1.5 x 10
6
 cells/mL, with MTT being the viability assay 
of choice. Generally, six triplicate sets of identical wells were made corresponding to the 
amount of acrylamide to be added in three days post-incubation. For example, acrylamide 
was added to obtain concentrations of 100, 10, 1, 0.1, and 0.01 mM with a sixth condition 
being a control without acrylamide. Each condition was replicated three times. After the 
addition of acrylamide, cultures were allowed to incubate for an additional two days prior 
to running the MTT assay. CT50 values were obtained and compared amongst the 
various conditions of dimensionality and collagen concentration. 
 
6.3.2 Axon retraction 
In order to observe and study the effects of acrylamide exposure on neuron maturation 
and function, immunocytochemistry was employed to allow for the visualization of the 
cell cultures. Collagen gel concentrations of 1 and 2 mg/mL were selected for study with 
a seeding density of 20,000 cells per chamber or 4 x 10
5
 cells/mL. Toxin concentrations 
were limited to 100, 10 and 1 mM acrylamide exposure with a control. In general, each 
condition was prepared in duplicate. An initial approach to setting up the hydrogels was 
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to carefully pipette a small drop of the cell and hydrogel mixture to the center of the 8-
well chamber slides, and promptly place it into the incubator for gelation. However, this 
yielded gels that dispersed into a flat layer, essentially coating the well rather than 
retaining a hemispherical structure. This issue was mitigated by increasing the amount of 
solution placed into each chamber; enough mixture was placed to completely cover the 
surface, and fill up approximately half of the chamber. These cultures were treated in the 
same manner as the cytotoxicity assay cultures where cells were allowed to grow for 
three days before toxins were added and then for another two days. These cultures were 
then fixed with PFA, and ICC techniques were applied: E/C8 primary antibody and a 
fluorescein conjugated secondary antibody were added; followed by the addition of DAPI 
and the removal of the chamber walls to allow for mounting. Cultures were studied under 
a fluorescence microscope and images were taken using a built-in camera (discussed in 
section 4.3). 
 
6.4 Results and Discussion 
6.4.1 Cytotoxicity results 
The initial experiments in 2D served as a proof of concept and in order to establish a 
baseline of comparison for the 3D hydrogel experiments. Cytotoxicity data for the 2D 
condition with wells coated with 1 mg/mL collagen is depicted in Figure 9. The CT50 
was estimated using a linear regression to be 4.48 mM ACR. 
 
Figure 9. Toxicity in 2D primary neuron cultures. Data represent the mean ± STDEV, n=3, and is double 
normalized. Obtained in Experiment 9. 
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These same cultures were qualitatively observed under a light microscope. Images were 
taken before ACR was added, and two days after for a comparison. Representative 
images are presented in Figure 10 between the 10 mM ACR and the 1 mM ACR 
condition as the CT50 value (4.48 mM ACR) was found between these two conditions. 
As shown in the comparative images, axons are largely still intact after two days of 
exposure to 1 mM ACR. In contrast, they have retracted under the 10 mM ACR 
condition. Furthermore, a larger number of cells in the post-toxin 10 mM ACR condition 
show a rounded shape suggesting a toxic response of significant axon retraction and 
compromised neuron maturation or death. 
 
 
Figure 10. Visualization of toxicity in 2D primary neuron cultures, cultured on 1 mg/mL collagen coated 
plates. a, c, Before the addition of toxin after 3 days of growth. b, d, After 2 days of culture with ACR 
toxin. Obtained in Experiment 9. 
 
For the three dimensional gels, ACR cytotoxicity assays were performed in collagen 
densities of 0.5, 1, and 2 mg/mL. The resulting cytotoxicity data is presented in Figure 
11. The CT50 values as gleaned from Figure 11 indicate that neurotoxic response of our 
particular cell type may be altered by the physical environment they are grown in. The 
least dense gel at 0.5 mg/mL collagen resulted in the lowest CT50 value (2.53 mM ACR) 
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signifying greater sensitivity to ACR. In contrast, the densest gel at 2 mg/mL yielded the 
highest CT50 value (8.80 mM ACR). It may be inferred then that collagen concentration, 
be it the density of the gel or the number of attachment points available, influences the 
cellular response to ACR. 
 
Figure 11. Toxicity in 3D primary neuron cultures. Data represent the mean ± STDEV, n=9 for 1 mg/mL 
n=6 for 0.5 and 2 mg/mL, and is double normalized. Obtained in Experiments 10 and 14. 
 
Furthermore, collagen concentration seems to influence neuronal maturation on the basis 
of attachment point availability rather than the relative stiffness of the gels. This is 
indicated through a comparison of the CT50 values across between 2D and 3D 
conditions, and is reported in Figure 12. The CT50 value for the 2D condition (4.48 mM 
ACR), which was coated with 1 mg/mL collagen had a similar CT50 value as its 1 
mg/mL counterpart in 3D (4.92 mM ACR). 
 
This suggests that the availability of ECM protein for cell attachment is a greater factor at 
play than dimensionality or stiffness. This conclusion is drawn from the assumption that 
in the 2D environment, the cells are exposed to a very stiff environment of the plastic 
substrate compared to softer hydrogel environment conferred by the gel. While stiffness 
is a relevant factor in this project, given the type of gels used—whose mechanicals 
properties have yet to be fully characterized—it appears that anchorage points play a 
larger role on survival. 
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Figure 12. Comparison of CT50 data, calculated using linear regression. Obtained in Experiments 9, 10, 
and 14. 
 
6.4.2 Axon measurement results 
For axon length quantification, images of at least ten neurons which were positive for 
axon growth were taken for each condition. The NeuronJ program was used to quantify 
axon length in a standardized manner. Figure 13 contains representative images of 
neurons grown in 1 mg/mL compared to 2 mg/mL collagen hydrogels at varying levels of 
ACR exposure. Axons at the 2 mg/mL are much longer than their 1 mg/mL counterparts 
regardless of the amount of toxin added. 
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Figure 13. Visualization of toxicity in 3D primary neuron cultures, cultured in 1 mg/mL (a, c, e, g) and 2 
mg/mL (b, d, f, h) collagen hydrogels. Images were taken at 40x magnification on a fluorescence 
microscope and processed in Adobe Photoshop. Cell nuclei are stained blue with DAPI, and green is the 
fluorescein-conjugated stain for neurofilament. Obtained in Experiment 13. 
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The previous conclusion that neuron viability is enhanced in 2 mg/mL collagen relative 
to 1 mg/mL collagen may be corroborated by the graph of axon length shown in Figure 
14. As seen in Figure 14, axon length measurements at each toxin concentration 
condition showed that the 2 mg/mL condition induced longer axons than 1 mg/mL. When 
toxin concentration is taken into account, there is a steady decrease of axon length as 
ACR concentration increases. This is best represented by the 2 mg/mL values which 
showed the most growth, indicating more mature axons. This suggests that ACR causes 
progressive axon retraction. 
 
The relationship between axon length and toxin concentration correlates to the CT50 
data, which revealed that more cells cultured in 2 mg/mL collagen were able to survive at 
a higher toxin concentration (CT50 of 8.8 mM ACR) than in the 1 mg/mL condition (CT 
50 of 4.92 mM ACR). This means that if cells are healthier and more resistant in the 2 
mg/mL gels, then it would likely follow that they would have longer axons. 
 
 
Figure 14. Average axon length in toxin-treated 3D collagen,  measured via NeuronJ ± STDEV. Images 
were taken under 40X magnification of at least 10 neurons per condition that showed positive neurite 
growth. Obtained in Experiment 13. 
 
Another conclusion we were able to make is that the axon retraction response is more 
sensitive than a lethal response to ACR. If we assume that the maximum level of axon 
length is attained at the 2 mg/mL condition without toxin, we obtain a concentration of 
neurotoxin necessary to reduce axon length by half. This value is arbitrarily named the 
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axon retraction 50, or AR50. The AR50 was calculated by normalizing the axon 
measurements to a scale whereby 0 mM was at 100% length potential and the 100 mM 
condition was at 0%. AR50 was determined by linear regression from the two points 
resulting from the normalization that lay closest to 50% growth potential on either side. 
This value is reported in Table 4 along with the CT50 values acquired from the 
cytotoxicity experiments. The calculated value for AR50 is 2.42 mM ACR, and means 
that neurons exposed to this concentration of ACR are assumed to have only half of their 
maximum length of axons. This AR50 value is well below the CT50 value for the same 2 
mg/mL condition it was derived from (Table 4). This suggests that while cells may 
survive at larger quantities at lower concentrations of acrylamide, the toxin still has non-
lethal detrimental effects that compromise neuronal health—characterized by shorter 
axons, which are key structural components that enable neurons to function normally. 
 
Table 4. Cell mortality versus axon retraction. We made the assumption that the maximum level of axon 
length is attained at the 2 mg/mL collagen condition without toxin, and then determined a concentration of 
toxin necessary to reduce the length by 50%. We have arbitrarily called this number the AR50*. 
 CT50 AR50* 
2D Collagen 4.48 mM ACR  
3D Collagen                     0.5 
mg/mL 
2.53 mM ACR  
1 mg/mL 4.92 mM ACR  
2 mg/mL 8.80 mM ACR 2.42 mM ACR 
 
6.4.3 Conclusion 
These results provide insight into the capacity of our proposed neurotoxicity screening 
system. As previously discussed in section 1.2.5, the goals of the neurotoxicity screen are 
to determine neurotoxic response that affect cell survival, generic cell functions, and 
neuron specific functions such as neurotransmission [21]. The cytotoxicity assay data was 
meant to establish a proof of concept that our three dimensional collagen hydrogel 
environment is capable of giving an output on cytotoxicity. The axon measurement data, 
on the other hand, was intended to present a more biologically relevant method of 
assessing the toxic profile of ACR with its ability to compromise neuronal maturation 
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and function by affecting axon outgrowth and inducing retraction. Since neuronal 
function is contingent on its axons, neurotoxic response that compromises its length 
would likely affect its ability to function as well. Multiple tests would need to be run to 
follow up this data to increase the robustness of the system as well as provide further 
proof of the system’s ability to serve as a neurotoxin screen. These tests will be discussed 
in the next chapter. 
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7. Conclusion 
7.1 Summary 
The goal of this project was to design a biomimetic, primary cell-based 3D scaffold to 
function as a system for toxicology screening. The first phase of the project involved 
establishing proper parameters for culturing this neuronal cell type in systems that 
encourage cell survival and maturation. This system was determined to be a pure collagen 
hydrogel with protein concentrations between 0.5 mg/mL to 2 mg/mL with prescribed 
seeding densities of 75,000 cells/well for cytotoxicity assaying and 20,000 cells/chamber 
for visualization. The next phase involved the addition of the ACR neurotoxin to the 
cultured cells in order to analyze and assess their response. This was a large project to 
undertake during the course of only one year, but significant progress was made toward 
achieving our goal. Troubleshooting with alginate-ECM protein composites during the 
first module gave us a general sense of which systems work. This knowledge provides a 
good platform on which to build from. The present system provides a point of 
comparison and a proof of concept for future work involving the design of more 
biomimetic scaffolds. 
  
7.2 Future Work 
Firstly, we have not yet fully characterized the mechanical properties of the collagen 
hydrogels. Preliminary experiments were run resulting in storage modulus values for the 
2 mg/mL collagen gels and the 1 mg/mL gels, whereby the former was approximately 
twice as large as the latter (data not shown). However, more comprehensive data is 
necessary. Understanding the stiffness of the different hydrogel conditions is important 
for comparing to in vivo tissues, as stiffness governs the pore sizes present within the 
scaffold and affects the ability of the cells to migrate and extend projections. 
  
Secondly, these experiments could be expanded to alginate-ECM protein composites as 
was explored in the first phase of the project. Alginate-based hydrogels enable more 
precise control over the stiffness while simultaneously preserving the number of 
attachment points available.  Changing alginate concentration modulates stiffness without 
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changing the number of attachment points, whereas when collagen concentration is 
altered in pure collagen gels the attachment point concentration is changed as well. 
Furthermore, alternative ECM proteins may be incorporated into the alginate hydrogel 
which are more biomimetic for neuronal culture, such as laminin. However, research and 
refinement on alginate composites must be performed to ensure that the resulting 
hydrogel is homogenous and presents attachment points throughout the gel since the 
ECM proteins may sink to the bottom of the hydrogel. 
  
An interesting direction for future work involves adjusting the time period of toxin 
exposure. Experiments thus far have been exposing cells to ACR for two days. We would 
like to observe the finer differences in axon length and survival at multiple time points 
such as 6, 12, 24, and 36 hours post-exposure. This would enable visualization of gradual 
axon retraction and would better characterize the mechanism by which acrylamide affects 
this cell type. 
  
Another future step is the addition of other toxins besides acrylamide. Obtaining data on 
more drugs would enable drawing a correlation to in vivo LD50 data established from 
living animal models. LD50 is the lethal dose at which 50 percent of a tested animal 
population is killed by a substance; it is the in vivo equivalent of the in vitro CT50. As 
referenced earlier, tests have been run for four different drug compounds resulting in a 
correlation plot between the CT50, in mM, and the LD50, in mmol/kg, for both their 2D 
and 3D CT50 data [23]. From this, they observed that the 3D culture system better 
correlated to the in vivo data then the 2D one; thereby concluding that their 3D 
environment was more biologically relevant in predicting toxin response. Performing 
such types of analysis is a future goal for this project. 
 
Furthermore, to meet the needs presented by Bal-Price et al. in the field of neurotoxicity 
screening, it would be beneficial to explore alternative ways with which to assess how 
neurotoxins affect neuronal function in a more direct manner. Performing protein 
expression analysis may be an avenue of interest to determine if certain proteins are 
upregulated or deregulated in response to neurotoxins. Also, as discussed in their paper, 
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applying new techniques to study electrical activity and neurotransmission to assess to 
what level they have been affected would be important in further enhancing the potential 
of this system [21]. 
  
Lastly, access to a confocal microscope would greatly improve our ability to assess the 
morphology of primary neurons in 3D hydrogels. Our system revolves around the 
concept of three-dimensionality, so the neurons extend their long, winding axons across 
multiple planes in many directions within the hydrogel—as we want them to. However, it 
poses the challenge of visualizing these projections in a standard fluorescence 
microscope given the distribution of cells across multiple vertical planes. It would be 
very interesting to see what kind of images could be obtained and if any novel data are 
uncovered using a more powerful tool for visualization. Confocal microscopes use point 
illumination and a pinhole technique to see one focal plane at a time and eliminate 
background from the surrounding environment. Instead of the entire gel or specimen 
being exposed to light and fluorescing all at once, only a single plane at a time fluoresces. 
Confocal microscopy enables the reconstruction of three-dimensional structures from the 
obtained images. 
 
7.3 Concluding Remarks 
As introduced in the section above, there are many future directions to take these 
experiments that we only able to begin to explore with the time and resources available. 
We hope to see this project continued forward by future Senior Design teams at Santa 
Clara University, and pursue related research in our own graduate studies. 
 
 
  
52 
 
Bibliography 
 
1. Volpato, F. Z., Führmann, T., Migliaresi, C., Hutmacher, D. W., & Dalton, P. D. 
(2013). Using extracellular matrix for regenerative medicine in the spinal cord. 
Biomaterials, 34(21), 4945–55. doi:10.1016/j.biomaterials.2013.03.057 
2. Yu, L. M. Y., Leipzig, N. D., & Shoichet, M. S. (2008). Promoting neuron adhesion 
and growth. Materials Today, 11(5), 36–43. 
3. Sur, S., Newcomb, C. J., Webber, M. J., & Stupp, S. I. (2013). Tuning supramolecular 
mechanics to guide neuron development. Biomaterials, 34(20), 4749–57. 
doi:10.1016/j.biomaterials.2013.03.025 
4. Aurand, E., Wagner, J., Lanning, C., & Bjugstad, K. (2012). Building Biocompatible 
Hydrogels for Tissue Engineering of the Brain and Spinal Cord. Journal of 
Functional Biomaterials, 3(4), 839–863. doi:10.3390/jfb3040839 
5. Fisher, K., Fedoroff, S. (2013). The Development of Chick Spinal Cord in Tissue 
Culture : I. Fragment Cultures from Embryos of Various Developmental Stages. 
Society for In Vitro Biology, 13(9), 569–579. Stable URL : 
http://www.jstor.org/stable/4291976. 
6. Hamburger, V., & Hamilton, H. (1951). A series of normal stages in the development 
of the chick embryo. Journal of Morphology, 88(1). 
7. Whalley, K., Gögel, S., Lange, S., & Ferretti, P. (2009). Changes in progenitor 
populations and ongoing neurogenesis in the regenerating chick spinal cord. 
Developmental Biology, 332(2), 234–45. doi:10.1016/j.ydbio.2009.05.569 
8. Gilbert, S. F. Developmental Biology. 6th edition. Sunderland (MA): Sinauer 
Associates; 2000. Formation of the Neural Tube. Available from: 
http://www.ncbi.nlm.nih.gov/books/NBK10080/. 
9. O’Connor, S. M., Stenger, D., Shaffer, K. M., & Ma, W. (2001). Survival and neurite 
outgrowth of rat cortical neurons in three-dimensional agarose and collagen gel 
matrices. Neuroscience Letters, 304(3), 189–93. Retrieved from 
http://www.ncbi.nlm.nih.gov/pubmed/11343834 
10. Matyash, M., Despang, F., Mandal, R., & Fiore, D. (2011). Novel Soft Alginate 
Hydrogel Strongly Supports Neurite Growth and Protects Neurons Against 
Oxidative Stress, 1–13. doi:10.1089/ten.tea.2011.0097 
11. Lai, Y., Cheng, K., & Kisaalita, W. (2012). Three dimensional neuronal cell cultures 
more accurately model voltage gated calcium channel functionality in freshly 
dissected nerve tissue. PloS One, 7(9), e45074. doi:10.1371/journal.pone.0045074 
12. Gotte, M., Hofmann, Micho-Gallani, A.I., Glickman, J.F., Wishart, W., and Gabriel, 
D. (2010). An imaging assay to analyze primary neurons for cellular neurotoxicity. 
Journal of Neuroscience Methods 192, 7-16. 
13. Cheng, T., Chen, M., Chang, W., Huang, M., & Wang, T.. (2013). Neural stem cells 
encapsulated in a functionalized self-assembling peptide hydrogel for brain tissue 
engineering. Biomaterials, 34(8), 2005–16. doi:10.1016/j.biomaterials.2012.11.043 
14. Wade, R. J., & Burdick, J. (2012). Engineering ECM signals into biomaterials. 
Materials Today, 15(10), 454–459. doi:10.1016/S1369-7021(12)70197-9 
15. Lee, K. Y., & Mooney, D. J. (2012). Alginate: properties and biomedical 
applications. Progress in Polymer Science, 37(1), 106–126. 
53 
doi:10.1016/j.progpolymsci.2011.06.003 
16. Alberts B, Johnson A, Lewis J, et al. Molecular Biology of the Cell. 4th edition. New 
York: Garland Science; 2002. The Extracellular Matrix of Animals. Available from: 
http://www.ncbi.nlm.nih.gov/books/NBK26810/ 
17. Ratner, Buddy D, et al. Biomaterial Science: An Introduction to Materials and 
Medicine.  Ed. Oxford: Academic Press, 2013. Print. 
18. Deister, C., Aljabari, S., & Schmidt, C. E. (2007). Effects of collagen 1, fibronectin, 
laminin and hyaluronic acid concentration in multi-component gels on neurite 
extension. Journal of Biomaterials Science. Polymer Edition, 18(8), 983–97. 
doi:10.1163/156856207781494377 
19. Tonge, D. a, de Burgh, H. T., Docherty, R., Humphries, M. J., Craig, S. E., & Pizzey, 
J. (2012). Fibronectin supports neurite outgrowth and axonal regeneration of adult 
brain neurons in vitro. Brain Research, 1453, 8–16. 
doi:10.1016/j.brainres.2012.03.024 
20. Proctor, R. A. (2014). Fibronectin: a brief overview of its structure, function, and 
physiology. Reviews of Infectious Diseases 9(4), 317–21. Retrieved from 
http://www.ncbi.nlm.nih.gov/pubmed/3326130 
21. Bal-Price, A. K., Hogberg, H. T., Buzanska, L., & Coecke, S. (2010). Relevance of in 
vitro neurotoxicity testing for regulatory requirements: challenges to be considered. 
Neurotoxicology and Teratology, 32(1), 36–41. doi:10.1016/j.ntt.2008.12.003 
22. Astashkina, A., Mann, B., & Grainger, D. W. (2012). A critical evaluation of in vitro 
cell culture models for high-throughput drug screening and toxicity. Pharmacology 
& Therapeutics, 134(1), 82–106. doi:10.1016/j.pharmthera.2012.01.001 
23. Lan, S.-F., & Starly, B. (2011). Alginate based 3D hydrogels as an in vitro co-culture 
model platform for the toxicity screening of new chemical entities. Toxicology and 
Applied Pharmacology 256(1), 62–72. doi:10.1016/j.taap.2011.07.013 
24. Horning, J. L., Sahoo, S. K., Vijayaraghavalu, S., Dimitrijevic, S., Vasir, J. K., Jain, 
T. K., Labhasetwar, V. (2008). 3-D tumor model for in vitro evaluation of anticancer 
drugs. Molecular Pharmaceutics 5(5), 849–862. 
25. Ramamoorthi, K., Hara, J., Ito, C., Asuri, P. (2014). Role of Three-Dimensional 
Matrix Stiffness in Regulating the Response of Human Neural Cells to Toxins. 
Cellular and Molecular Bioengineering 7(2), 278-284. 
26. U.S. Environmental Protection Agency (1994). Chemical Summary for Acrylamide. 
Office of Pollution Prevention and Toxics (EPA 749-F-94-005a). Retrieved from 
http://www.epa.gov/chemfact/s_acryla.txt. 
27. Park, H. R., Kim, M.-S., Kim, S. J., Park, M., Kong, K. H., Kim, H. S., … Lee, J. 
(2010). Acrylamide induces cell death in neural progenitor cells and impairs 
hippocampal neurogenesis. Toxicology Letters, 193(1), 86–93. 
doi:10.1016/j.toxlet.2009.12.015 
28. Brown, R. C. (2005). Neurodegenerative diseases: An overview of environmental risk 
factors. Environmental Health Perspective 113(9), 1250-1256.  
29. “Alternatives to animal testing gaining ground.” (2010). The Baltimore Sun. 
Retrieved from http://www.techzone360.com/news/2010/08/27/4978009.htm. 
30. Herper, M. (2010) “The Truly Staggering Cost Of Inventing New Drugs.” Forbes. 
Retreived from http://www.forbes.com/sites/matthewherper/2013/08/11/how-the-
staggering-cost-of-inventing-new- drugs-is-shaping-the-future-of-medicine/. 
54 
31. American Type Culture Collection. (2011). MTT Cell Proliferation Assay Instruction 
Guide. Retrieved from 
http://www.atcc.org/~/media/DA5285A1F52C414E864C966FD78C9A79.ashx 
32. Dojindo Molecular Technologies, Inc.(2013). Cell Counting Kit-8 Technical Manual. 
Retrieved from: http://www.dojindo.com/technicalmanual/manual_ck04.pdf 
33. Fotakis, G. and Timbrell, J.A. (2006). In vitro cytotoxicity assays: Comparison of 
LDH, neutral red, MTT and protein assay in hepatoma cell lines following exposure 
to cadmium chloride. Toxicology Letters 160, 171-177. 
34. Tominaga, H., Ishiyama, M., Ohseto, F., Sasamoto, K., Hamamoto, T., Suzuki, K., 
Watanabe, M. (1999). A water-soluble tetrazolium salt useful for colorimetric 
viability assay. Analytical Communications 36, 47-50.  
35. Ishiyama, M., Shiga, M., Sasamoto, Mizoguchi, M., and He, P. (1993). A New 
Sulfonated Tetrazolium Salt That Produces a Highly Water-Soluble Formazan Dye. 
Chemical and Pharmaceutical Bulletin 41(2), 1118-1122. 
36. Ramos-Vara, J.A.  (2005). Technical Aspects of Immunohistochemistry. Veterinary 
Pathology 42, 405-426. 
37. Burry, R.W. (2011). Controls for Immunocytochemistry: An Update. Journal of 
Histochemistry & Cytochemistry 59(1), 6-12. 
38. Ciment, G., Ressler, a, Letourneau, P. C., & Weston, J. a. (1986). A novel 
intermediate filament-associated protein, NAPA-73, that binds to different filament 
types at different stages of nervous system development. The Journal of Cell 
Biology, 102(1), 246–51. Retrieved from 
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2114046&tool=pmcentre
z&rendertype=abstract 
39. Meijering, E., Jacob, M., Sarria, J. F., Steiner, P., Hirling, H., Unser, M. ( 2004). 
Design and validation of a tool for neurite tracing and analysis in fluorescence 
microscopy images. Cytometry, 58(2), 167-176. 
 
 
 
 
 
 
 
 
 
  
A-1 
 
Appendices 
 
Appendix A: Preliminary Study Findings 
Table 5. Descriptive statistics and variables for various 3D neuron culture conditions. The average and 
standard error were calculated for average neuron cell survival, average neurite outgrowth, and average 
neurite length. Percent cell survival was calculated for each individual culture plate. 
  Neuron survival: Condition 
Number of 
plates Average cell number Standard error 
 0.25% DAPI+ N=16 138.16 15.56 
 1% DAPI+ N=16 23.68 3.77 
 Control DAPI + N=4 71.57 3.00 
 0.25% CYTO+ N=16 79.47 10.04 
 1% CYTO+ N=16 13.95 3.16 
 Control CYTO + N=4 12.63 4.21 
Neurite 
outgrowth: Condition 
Number of 
plates Percent positive growth Standard error 
 0.25% N=16 80% 0.03 
 1% N=16 26% 0.06 
 Control N=4 5% 0.05 
Neurite length: Condition 
Number of 
plates 
Average length (grid 
units) Standard error 
 0.25% N=4 18.725 5.535096356 
 1% N=4 2.675 0.778219121 
 Control N=4 N/A N/A 
 
Percent cell survival: 0.25% Alginate 1% Alginate Control 1 Control 2 
Avg cell/area 32.81 17.00 5.50 5.63 
Avg cell/well 11052.63 12884.21 4168.42 1894.74 
Divided by theoretical 
cell count per well 1.84 0.32 0.10 0.32 
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Figure 15a. Percent cell survival on 0.25% and 1% alginate 3D gels and 2D controls. This percentage was 
determined by calculating the average number of cells per well and dividing by the theoretical value of 
cells per well.  
 
 
Figure 15b. Average neurite length in 0.25% and 1% alginate 3D gels. Lengths were averaged for neurons 
with multiple outgrowths. Four images were analyzed per alginate plate. One control plate was counted and 
had only one neuron with length 1, therefore there was not enough data to construct an average or standard 
error for the 2D controls.  
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Appendix B: Budget 
Table 6. Complete itemized budget 
Reagent Company Catalog # Amount Quote Quantity Price 
Neurobasal Medium (1X), 
Liquid Life Technologies 21103-049 500 mL 47.60 1 $47.60 
B-27 Supplement Life Technologies 17504-044 10 mL 68.65 1 $68.65 
Penicillin-Streptomycin-Glutamine 
(100X) Life Technologies 10378-016 100 mL 15.65 1 $15.65 
HBSS, no Calcium, no 
Magnesium Life Technologies 14170-112 500 mL 10.42 1 $10.42 
0.25% Trypsin-EDTA (1X) Life Technologies 25200-056 10 mL 6.94 1 $6.94 
Advanced DMEM Life Technologies 12491-015 500 mL 23.20 4 $92.80 
DPBS, no Calcium, no 
Magnesium Life Technologies 14190-136 1 L 17.48 1 $17.48 
E/C8 antibody mouse IgM 
Developmental Studies 
Hybridoma Bank N/A 1 mL 32.00 2 $64.00 
Goat anti-mouse IgM-FITC 
Santa Cruz Biotechnology, 
Inc. SC-2082 0.5 mL 0.00 1 $0.00 
Sodium Alginate Sigma-Aldrich A1112 100 g 37.70 1 $37.70 
Laminin Mouse Protein, 
Natural Life Technologies 23017-015 1 mg 0.00 1 $0.00 
Collagen I Rat Protein, Tail Life Technologies A1048301 20 mL 146.70 1 $146.70 
Cell-Counting Kit-8 (WST-8) Dojindo CK04-11 10 mL 170.00 1 $170.00 
Eggs Whole Foods N/A 1 dozen 3.79 20 $75.80 
Fibronectin Bovine Protein, 
Plasma Life Technologies 33010-018 1 mg 0.00 1 $0.00 
Normal Goat Serum 
Jackson ImmunoResearch 
Laboratories 005-000-121 10 ml 50.00 1 $50.00 
Miscellaneous       
Shipping and Tax Various N/A N/A 500.00 N/A $500.00 
Misc. Reagents Various N/A N/A 300.00 N/A $300.00 
Lab Supplies       
200 ul pipet tips VWR 89140-936 960 33.18 1 $33.18 
1000 ul pipet tips VWR 89168-754 768 46.10 1 $46.10 
96-well round bottom plates VWR 82050-634 60 112.47 1 $112.47 
1.5 ml Microcentrifuge tubes VWR 89126-724 500 8.72 1 $8.72 
   Total:   $1,804.21 
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Appendix C: Gantt Chart 
Table 7. Gantt chart of the project schedule and task assignments in the winter and spring quarters 2014 
 
Task Owner Prior 1.  Jan 6 
2.  
Jan 
13 
3.  
Jan 
20 
4.  
Jan 
27 
5.  
Feb 3 
6.  
Feb 
10 
7.  
Feb 
17 
8.  
Feb 
24 
9.  
Mar 
3 
10.  
Mar 
10 
1. 
Mar 
31 
2.  
Apr 7 
3.  
Apr 
14 
4.  
Apr 
21 
5.  
Apr 
28 
6.  
May 
5 
7.  
May 
12 
8.  
May 
19 
9.  
May 
26 
10.  
Jun 2 
Preliminary 
experiments 
Nicolo, 
Jessica                      
Team meeting 
with P.I.s Team                      
Final Project 
Proposal Team                      
Obtain eggs 
Teresa, 
Jessica                      
Prepare alginate 
Nicolo, 
Teresa                      
First draft of thesis Team                      
Experiment 1:  
Cell density Team                      
Experiment 2:  
2D ECM protein analysis Team                      
Experiment 3:  
Cell density + alginate 
stiffness Team                      
Experiment 4:  
ECM protein density in 2D Team                      
Experiment 5:  
ECM protein density in 3D Team                      
Experiment 6:  
2D cell density + assay 
signal determination Team                      
Experiment 7:  
Toxicity in 2D and 3D 
laminin, for assaying Team                      
Experiment 8:  
Analysis of U87 cells in 2D 
and 3D Team                      
Experiment 9: 
Toxicity on 2D laminin and 
collagen, for assaying and 
visualization Team                      
Experiment 10: 
Toxicity in 3D  collagen, for 
assaying Team                      
Experiment 11: 
Mechanical 
charachterization Team                      
Experiment 12: 
Toxicity in 3D collagen, for 
visualization Team                      
Experiment 13: 
Toxicity in 3D collagen, for 
visualization Team                      
Experiment 14: 
Toxicity in 3D collagen, for 
assaying Team                      
Experiment 15: 
Mechanical characterization Team                      
SD conference 
presentation Team                      
Final thesis Team                      
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Appendix D: Dissection and Dissociation Protocol 
 
TITLE  Chick Embryo Dissection 
 
PURPOSE  To practice proper chick embryo dissection techniques: specifically, spinal 
cord isolation and dissociation, dorsal root ganglia extraction, and 
extraction of similarly-sized explants; also separation of neurons from 
glial cells. 
 
Notes: (1) Materials and Methods derived from Neurobiology Lab 
Protocols provided by Dr. Sabatier during spring 2013. (2) Before 
dissecting, make sure to have a full stomach, but avoid excessive sugar or 
caffeine to prevent physiological impedance during dissection. 
 
MATERIALS 
 
Lab supplies: 
1 ice bucket 
4+ fertilized eggs (Embryonic Day 6) in egg carton 
1 Dissection microscope and light source 
5 mL syringe with 16 G needle 
10 cm petri dish 
6 cm petri dish 
10 cm Sylgard coated plate 
1 embryo scoop 
1 razor blade 
1 dissection scissors 
1 fine forceps 
1 dissection (blunt) forceps 
1 hemocytometer 
2 15 mL centrifuge tubes 
2 Pasteur pipettes 
1 fire-polished Pasteur pipette 
1 pipet gun 
2 5 mL serological pipettes 
 
Reagents:  
50 mL Advanced Dulbecco’s Modified Eagle Medium (DMEM) 
17 mL DMEM + 10% Fetal Bovine Serum 
10 mL Hank’s Buffered Saline Solution (HBSS) 
1 mL 0.25% Trypsin/EDTA 
10 mL Neurobasal/Pen-Strep/B-27 Media 
 
METHODS 
 
Dissection: 
D-2 
1.    Collect eggs from incubator (incubating for 6-7 days) and place eggs horizontally 
(blunt and sharper ends facing sides) on egg carton to allow for yoke to migrate to 
the top. Let sit for at least 5 minutes. 
2.    Set up the rest of dissection materials: 
a.    Set up dissection microscope near a power outlet; plug in light source and place 
just behind the scope; adjust the lights such that they are clearly lighting up the 
stage while not impeding ability to access the middle of the stage; adjust focus 
by placing fine forceps under lens and calibrating such that the details on the 
metal can be clearly seen. 
b.    Do this after scoring egg to ensure DMEM is still cold: Add ~15 mL of cold 
Advanced DMEM in a 10 cm petri dish and add ~10 mL of cold Advanced 
DMEM in a Sylgard-coated 10-cm plate. 
c.    Add 5 mL of cold HBSS into a 15 mL centrifuge tube (A) and place on ice. 
3.    Using the 16 G needle with a 5 mL syringe, gently poke a hole on the blunt side of 
the egg and slowly remove 3-5 mL of albumin (egg white) while carefully avoiding 
the embryo (insert slightly deeper once hole is made as the blunt end may have an air 
pocket); this process lowers the embryo and creates a space to allow for creating a 
viewing window. 
4.    Score a 1 in. by 1 in. square window on the top of the egg, and using a set of forceps 
start peeling away the eggshell to expose the contents of the egg. 
5.    Once a sufficiently large window has been made, use forceps to grab the membrane 
surrounding the embryo and raise it up gently. Use a pair of dissection scissors to 
excise the embryo from the vasculature in the egg. Then use an embryo scoop to 
transfer the embryo into the 10 cm petri dish. 
6.    Consult the Hamburger and Hamilton sheet to determine the stage of the embryo and 
record; ideally the stage should be within the 25-30 stage range. 
7.    Remove the extraembryonic tissues surrounding the embryo; this should appear to be 
a thin semi-translucent film around the embryo. 
8.    Transfer the embryo into the 10 cm Sylgard-coated petri dish containing DMEM. 
9.    Remove the head above the forelimbs and the lower half of the body just above the 
hindlimbs; do so by using a pair of dissection forceps; push these to the side. 
10.  Place the petri dish onto the dissection scope stage and adjust to get proper lighting. 
11.  Orient the embryo with the chest facing up, pin down the body using the blunt 
dissection forceps in one hand, and use a pair of fine forceps in the other hand to 
remove internal organs (i.e. heart, lungs, liver); avoid causing damage or cutting 
through to the back of the embryo; remove slowly and with a light touch. 
12.  Once the spinal cord is visible (appears like a thin white line at the dorsal part of the 
body), begin cutting connective tissue on the cord’s edges, and pull off the thin layer 
of tissue covering the spinal cord; what should remain is the spinal cord and a layer 
of tissue beneath the spinal cord. 
13.  Gently grab the spinal cord and pull it out of the embryo; do so slowly, and avoid 
breaking the spinal cord; the main spinal cord contains motor neurons and 
interneurons, and dorsal root ganglia (DRG) may be found still attached to the spinal 
cord or in the underlying tissue beneath the spinal cord; these appear spherical and 
may be picked individually. 
14.  Repeat for the desired amount of embryos; suggested number is 4 (2-3 embryos may 
D-3 
suffice depending on size). 
 
Dissociation: 
1. Cut up the spinal cord into small, equal-sized segments. 
2. Rinse a Pasteur pipette with DMEM + 10% FBS, and use it to transfer the spinal 
cord section to the centrifuge tube (A) containing 5 mL HBSS; keep it in an ice 
bucket; keep the spinal cords from going up to the pipette. 
3. Centrifuge the spinal cords down for 1 minute at 500 rpm (provide a proper 
balance). 
4. Discard the supernatant using a Pasteur pipette. 
5. Wash remnants with 5 mL HBSS, and repeat steps 3 and 4. 
6. Add 1 mL 0.25% Trypsin-EDTA to centrifuge tube (A) and incubate in 37°C water 
bath for 15 minutes; shake the tube every 3-5 minutes. 
7. Add 10 mL DMEM + FBS to the tube (A) to cease trypsinization reaction. 
8. Spin down for 1 minute at 500 rpm (provide a proper balance); discard supernatant. 
9. Resuspend spinal cords in 1 mL DMEM + FBS, and triturate spinal cord segments 
up and down the pipette (do so until no chunks are visible). 
10. Let stand on ice for 2-3 minutes to allow larger chunks to settle. 
11. Transfer supernatant into a new 15 mL centrifuge tube (B) containing 5 mL DMEM 
+ FBS. and spin down cells for 5 minutes at 2000 rpm (found in tissue culture room; 
balance appropriately). 
 
Note: We placed centrifuge tube (B) in closed ice-bucket to allow for transport to Tissue 
Culture Lab in Bannan Engineering Labs building. 
 
12. Discard supernatant and resuspend pellet in 1 mL NeuroBasal/Pen-Strep/B-27 
Culture media; pipette until no chunks are visible. 
 
Cell counting: 
1. Properly disinfect centrifuge tube (B) before placing in culture hood; resuspend 
pellet once again, and let sit for a while (2-3 minutes). 
2. Using a P-20, transfer 11 µL of dissociated cell solution into a disposable 
hemocytometer; place into two chambers (A and B) and count under a light 
microscope. 
3. Determine the amount of cells, and dilute with Neurobasal/Pen-Strep/B-27 Cell 
Culture Media to the desired concentration and amount. 
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Appendix E: Immunocytochemistry Fixing Protocol 
 
TITLE Cell Fixing for Immunocytochemistry 
 
PURPOSE To immobilize cells for antibody staining and visualization. 
 
MATERIALS 
 
Lab supplies: 
1 P200 pipette and tips 
 
Reagents: *volumes dependent on number of wells to be fixed 
1X PBS 
4% Paraformaldehyde solution 
Blocking Buffer: PBS + 5% goat serum + 0.1% Triton X-100 
 
METHODS 
 
1. Remove media from each well using a P200 pipette. 
2. Wash each gel with 100 µL PBS; let sit 2-3 minutes. 
3. Add 100 µL 4% PFA to each well, inside a fume hood. 
4. Allow the PFA to fix the cells for 30 minutes for 3D plates, 15 minutes for 2D. 
5. Remove PFA into PFA waste container. 
6. Wash with 100 µL PBS; let sit 2-3 minutes. Repeat 2 more times. 
7. Remove PBS and add 50 µL Blocking buffer to each well. 
8. Store in 4°C refrigerator until staining in 1 day to 1 week. 
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Appendix F: Immunocytochemistry Staining Protocol 
 
TITLE Immunocytochemistry Cell Staining 
 
PURPOSE To stain the nuclei and neurofilament of cells in in vitro culture for 
visualization under fluorescence microscope. 
 
MATERIALS 
 
Lab supplies: 
P200 pipettes and tips 
Aluminum foil 
Rocking platform 
 
Reagents: *volumes dependent on number of wells to be stained 
Blocking Solution: 1X PBS + 5% goat serum + 0.1% Triton X-100 
Washing Solution: 1X PBS + 0.1% Triton X-100 
Primary e/c8 mouse IgM antibody 
Secondary goat anti-mouse IgM antibody 
DAPI, 1 mg/ml stock 
1X PBS 
 
METHODS 
 
Antibody dilutions: 
1. Prepare a 1:10 dilution of primary e/c8 mouse IgM antibody in Blocking Solution. 
2. Prepare a 1:200 dilution of secondary goat anti-mouse IgM antibody in Blocking 
Solution (do not make this dilution until Day 2 when it will be used). 
3. Prepare a 1:200 dilution (5 μg/mL) of DAPI in PBS (do not make this dilution until 
Day 3 when it will be used). 
 
3D plates: 
1. Empty well plates of blocking solution using manual pipetting techniques.  
2. Place 75 μL of primary antibody solution into each well. 
3. Refrigerate overnight. 
4. Use a pipette to remove excess primary antibody solution. 
5. Wash with 100 μL Washing Solution. Let sit for 1 hour on rocking platform, then 
remove Washing Solution. Repeat 3x.  
6. Wash with 100 μL Blocking Solution. Let sit for 1 hour on rocking platform, then 
remove Blocking Solution. Repeat 2x.  (Total of 5 washes.) 
7. Pipette 75 μL goat anti-mouse IgM secondary antibody (1:200 diluted) into each 
well. 
8. Refrigerate overnight.  
9. Use a pipette to remove excess secondary antibody solution. 
10. Wash with 100 μL Washing Solution and incubate on rocking platform for 1 hour 
covered with aluminum foil, then discard Washing Solution. Repeat 3x. 
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11. For fourth wash, add 75 μL DAPI+PBS solution. Let this wash sit for 10 minutes, 
then remove and add 5th wash of Washing Solution. (Total of 5 washes.)  
12. Remove 5th wash and add 75 μL of 1X PBS.  
13. Store in the dark at 4°C. Lasts for up to 1 month. 
 
2D plates: 
1. Empty wells of Blocking Solution using a manual pipette.  
2. Add 50 μL primary antibody to each well. 
3. Refrigerate overnight. 
4. Remove excess primary antibody solution using a manual pipette.  
5. Pipette 50 μL Blocking Solution into wells for 5 minutes and discard. Repeat 3x.  
6. Add 50 μL secondary antibody solution to each well. 
7. Incubate plates in refrigerator for 1 hour covered.  
8. Wash each well with 50 μL Washing Solution, incubate in dark drawer for 5 
minutes, and discard washes. Repeat 3x. 
9. For each well, place 50 μL DAPI dropwise in each well.  
10. Store in the dark at 4°C. Lasts for up to 1 month. 
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Appendix G: Experiment 1 and 2 Protocol 
 
TITLE         Cell Density and WST Signal Determination 
 
PURPOSE To determine the appropriate cell density required to obtain a feasible 
signal for conducting viability assays using WST. 
 
DATE        1/17/2014 
  
MATERIALS 
  
Lab Supplies: 
1 96-well plate 
Ice bucket, ice in ziplock bag 
P-1000, P-200, P-20, P-10 pipettes and pipette tips 
5 mL serological pipettes and pipette gun 
2 15 mL centrifuge tubes. 
25 sterile 1.6 mL microcentrifuge tubes 
 
Reagents: 
1 mL stock 500 mM CaCl2 
30+ mL of Neurobasal media containing pen-strep and B-27 supplement 
2 mL of stock 3% alginate 
300 µL of stock 3 mg/mL collagen 
10 µL of 1M sterile NaOH, 200 µL of 10X sterile PBS 
6 µL of 1 mg/mL laminin and fibronectin 
  
METHODS 
  
Dissection: 
Follow the protocols outlined in the Chick Embryo Dissection document. Take note of 
Hamburger and Hamilton embryonic stages. 
  
Note: Please keep every solution on ICE. This is most important for solutions that will be 
mixed with stock collagen prior to gelation. Remember that collagen gels when exposed 
to neutral pH and relatively warm temperatures. 
  
Aliquot Preparation: 
Note: If 0.25% alginate seems insufficiently viscous and there is concern that it won’t 
form a stable hydrogel, dilute to 1% alginate rather than 0.5% alginate. 
1.    Prepare 100 mM CaCl2 by taking 1 mL stock 500 mM CaCl2 and placing into a 15 
mL centrifuge tube and then adding 4 mL Neurobasal media. Place into the fridge or 
ice bucket immediately and replace between each use. (Good for 50 wells) 
2.    Dilute 3% stock alginate solution to 0.5% alginate by taking 217 µL of 3% stock 
alginate and adding 1083 µL of Neurobasal culture media for a total of 1.3 mL of 
0.5% alginate. (note: 220 and 1080 round-offs would work, too) 
a.    For 1% alginate: 433 µL of stock alginate + 867 µL NB media (or 435 + 865) 
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3.    Mix well by vortexing. 
4.    Place 145 µL of 0.5% alginate into 8 separate 1.6 mL sterile microcentrifuge tubes 
(corresponding to column #; please see aliquot breakdown for labeling and contents). 
5.    Make sure these aliquots remain cold by placing on ice or into the fridge. 
Note: Before moving forward, due to the gelation of two different gels, it may be best to 
work on one column (one aliquot) at a time and then proceed to plating and gelation 
process before moving on. 
6.    Place 20 µL of cold 10X PBS and 1 µL of cold 1M NaOH into each aliquot. 
7.    Place 34 µL of stock 3 mg/mL collagen into each aliqot. 
8.    Vortex and place immediately on ice. Once steps 6 and 7 are done for one aliquot; it 
is recommended to proceed to plating before making a second aliquot. 
  
Plating & Gelation: 
Note: Each aliquot for each column is “good” for 5 wells with a 50 µL excess. 
1.    Take aliquot for one column and add 100 µL of desired cell density; breakdown for 
cell density provided in Aliquot Breakdown section. Note: aliquot for column 9 
should have NO cells. 
Note: If not enough cells for the highest two or three cell densities, take the highest 
possible count and plate from there; the lower end cell densities should provide no 
issue. Consider doing serial dilutions to conserve microcentrifuge tubes. 
2.    Gently and thoroughly mix by pipetting solution up and down. 
3.    Work quickly so as to maintain cool temperature to avoid collagen gelation. 
4.    Place 96-well plate on top of a relatively flat sterilized Ziplock bag containing ice to 
keep the well plate cool. 
5.    Place 50 µL of aliquoted solution into each well for the designated column. For this 
experiment, rows B-E will be filled for each row. Please see Figure 1 for visual 
configuration of the well plate. 
6.    Once a particular column has been filled; add 100 µL of cool 100 mM CaCl2 to begin 
alginate gelation. 
7.    Let it sit on makeshift ice pack for 10 minutes before proceeding. This would be a 
good time to move onto the next column; and alternating back and forth as each 10 
minute interval has passed. 
8.    Once 10 minutes has passed, add 50 µL warm Neurobasal media into each well and 
then remove 50 µL from each well. Do this three times total for each well. 
9.    Once all wells are done (including Controls) place in 37°C and 5% CO2 incubator for 
three days. 
 
Controls: 
Note: These controls should have NO cells in them. 
1.    Column 9 and its corresponding aliquot should be plated and gelled in the same 
fashion as the previous 7 wells. 
2.    Alginate aliquots for columns 10 and 11 may be made by first making an aliquot of 
500 µL of 0.75% alginate; this is made by mixing 125 µL stock 3% alginate and 375 
µL Neurobasal media. 
a.    For 1.5% alginate, mix 250 µL each of stock 3% alginate and Neurobasal 
media 
3.    Column 10’s aliquot may be made by the addition of 100 µL of 30 µg/mL laminin, 
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100 µL of 0.75% alginate, and 100 µL of Neurobasal media. 
a.    Take 6 µL of 1 mg/mL laminin solution and dilute with 194 µL of sterile 
HBSS to make 30 µg/mL laminin. 
4.    Column 11’s aliquot may be made by the addition of 100 µL of 30µg/mL 
fibronectin, 100 µL of 0.75% alginate, and 100 µL of Neurobasal media. 
a.    Take 6 µL of 1 mg/mL fibronectin solution and dilute with 194 µL of sterile 
HBSS to make 30 µg/mL fibronectin. 
5.    Plate 50 µL into each corresponding well of Columns 10 and 11, and subsequently 
add 100 µL of 100 mM CaCl2 for 10 minutes when each column is done. 
6.    Add 50 µL of Neurobasal to each well and remove 50 µL from each well; perform 3 
times. 
7.    Additional controls may be made in any of the blackened or empty wells as shown in 
Figure 1. These controls may be made up of Neurobasal only. 
  
Aliquot Breakdown: 
Column 2: 20 µL 10X PBS + 1 µL 1M NaOH + 34 µL stock collagen + 145 µL of 0.5% 
alginate + 100 µL solution of 6.0*10
4
 cells/mL 
Column 3:  20 µL 10X PBS + 1 µL 1M NaOH + 34 µL stock collagen + 145 µL of 0.5% 
alginate + 100 µL solution of 1.2*10
5
 cells/mL 
Column 4: 20 µL 10X PBS + 1 µL 1M NaOH + 34 µL stock collagen + 145 µL of 0.5% 
alginate + 100 µL solution of 1.8*10
5
 cells/mL 
Column 5: 20 µL 10X PBS + 1 µL 1M NaOH + 34 µL stock collagen + 145 µL of 0.5% 
alginate + 100 µL solution of 2.4*10
5
 cells/mL 
Column 6: 20 µL 10X PBS + 1 µL 1M NaOH + 34 µL stock collagen + 145 µL of 0.5% 
alginate + 100 µL solution of 3.0*10
5
 cells/mL 
Column 7: 20 µL 10X PBS + 1 µL 1M NaOH + 34 µL stock collagen + 145 µL of 0.5% 
alginate + 100 µL solution of 1.5*10
6
 cells/mL 
Column 8: 20 µL 10X PBS + 1 µL 1M NaOH + 34 µL stock collagen + 145 µL of 0.5% 
alginate + 100 µL solution of 3.0*10
6
 cells/mL 
Column 9: 20 µL 10X PBS + 1 µL 1M NaOH + 34 µL stock collagen + 145 µL of 0.5% 
alginate + 100 µL solution of Neurobasal Media 
Column 10: 100 µL of 30 µg/mL laminin + 100 µL of 0.75% alginate + 100 µL solution 
of Neurobasal Media 
Column 11: 100 µL of 30 µg/mL fibronectin + 100 µL of 0.75% alginate + 100 µL 
solution of Neurobasal Media 
  
Note: If 0.5 % alginate is deemed more appropriate (dependent on viscosity): 
  
Column 2: 20 µL 10X PBS + 1 µL 1M NaOH + 34 µL stock collagen + 145 µL of 1% 
alginate + 100 µL solution of 6.0*10
4
 cells/mL 
Column 3:  20 µL 10X PBS + 1 µL 1M NaOH + 34 µL stock collagen + 145 µL of 1% 
alginate + 100 µL solution of 1.2*10
5
 cells/mL 
Column 4: 20 µL 10X PBS + 1 µL 1M NaOH + 34 µL stock collagen + 145 µL of 1% 
alginate + 100 µL solution of 1.8*10
5
 cells/mL 
Column 5: 20 µL 10X PBS + 1 µL 1M NaOH + 34 µL stock collagen + 145 µL of 1% 
alginate + 100 µL solution of 2.4*10
5
 cells/mL 
Column 6: 20 µL 10X PBS + 1 µL 1M NaOH + 34 µL stock collagen + 145 µL of 1% 
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alginate + 100 µL solution of 3.0*10
5
 cells/mL 
Column 7: 20 µL 10X PBS + 1 µL 1M NaOH + 34 µL stock collagen + 145 µL of 1% 
alginate + 100 µL solution of 1.5*10
6
 cells/mL 
Column 8: 20 µL 10X PBS + 1 µL 1M NaOH + 34 µL stock collagen + 145 µL of 1% 
alginate + 100 µL solution of 3.0*10
6
 cells/mL 
Column 9: 20 µL 10X PBS + 1 µL 1M NaOH + 34 µL stock collagen + 145 µL of 1% 
alginate + 100 µL solution of Neurobasal Media 
Column 10: 100 µL of 30 µg/mL laminin + 100 µL of 1.5% alginate + 100 µL solution of 
Neurobasal Media 
Column 11: 100 µL of 30 µg/mL fibronectin + 100 µL of 1.5% alginate + 100 µL 
solution of Neurobasal Media 
 
 
Figure 16. Experiment 1 and 2 configuration. Columns 2-8 correspond to cell density of cells grown on 
alginate-collagen composites. ACC, LCC, and FCC refer to control composite gels free from cells.  
 
Pre-lab Protocols: 
 Stock 3% alginate preparation: 
Weight out ~0.3 g of low viscosity alginate and add 10 mL of DI water. Place on a stir 
plate with magnetic stir bar and let sit overnight until solid has completely dissolved. 
Place in fridge until ready for autoclave and use within 2 weeks. 
Stock 500 mM CaCl2: 
Weight out 1.11 g of CaCl2 and add 20 mL of DI water and vortex until completely 
dissolved and sterile filter before use. 
Stock fibronectin preparation: 
Reconstitute with 1 mL sterile DI water and incubate for 30 mins at 37°C. Provide no 
agitation and left-over solid is normal. Further dilutions will be done using sterile HBSS. 
Make aliquots of the following sizes: 1x of 400 µL 1 mg/mL fibronectin (or 2x of 200 
µL) 2x of 200 µL 1 mg/mL fibronectin and 2x of 100 µL 1 mg/mL fibronectin. Store 
aliquots at -20°C. 
Stock laminin preparation: 
Make aliquots of the following sizes: 1x of 400 µL 1 mg/mL laminin (or 2x of 200 µL) 
2x of 200 µL 1 mg/mL laminin and 2x of 100 µL 1 mg/mL laminin. Store larger aliquots 
G-5 
at -80°C and smaller aliquots of 100 µL in -20°C. 
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Appendix H: Experiment 3 Protocol 
 
TITLE Cell Density and Alginate Stiffness Determination 
 
PURPOSE To determine the appropriate amount of cells needed per well in addition 
to the different effects of alginate stiffness on survival.  
 
DATE  1/24/2014  
  
MATERIALS 
  
Lab Supplies: 
6 96-well plates 
Ice bucket, ice in ziplock bag  
P-1000, P-200, P-20, P-10 pipettes and pipette tips  
5 mL serological pipettes and pipette gun  
2 15 mL centrifuge tubes.  
1 50 mL centrifuge tube  
40 sterile 1.6 mL microcentrifuge tubes  
 
Reagents: 
5 mL stock 500 mM CaCl2  
At least 100 mL of Neurobasal media containing pen-strep and B-27 supplement  
8 mL of stock 3% alginate  
1mL of stock 3 mg/mL collagen  
25 µL of 1M sterile NaOH, 500 µL of 10X sterile PBS  
6 µL of 1 mg/mL laminin and fibronectin  
  
  
METHODS 
  
Dissection:  
Follow the protocols outlined in the Chick Embryo Dissection document. Take note of 
Hamburger and Hamilton embryonic stages. 
Note: Please keep every solution on ICE. This is most important for solutions that will be  
mixed with stock collagen prior to gelation. Remember that collagen gels when exposed  
to neutral pH and relatively warm temperatures.  
  
Aliquot Preparation:   
1. Prepare 100 mM CaCl2 by taking 4.6 mL stock 500 mM CaCl2 and placing into a 50 
mL centrifuge tube and then adding 18.4 mL Neurobasal media. Place into the fridge 
or ice bucket immediately and replace between each use. (Good for 230 wells).  
2. Prepare aliquots for all setups by placing the 267 µL of 6% stock alginate into 18 
microfuge tubes (4% final concentration) and 200 µL (3% final concentration) into 
another set of 18 microfuge tubes. Labeling scheme is explained in the aliquot 
breakdown section.  
3. Prepare laminin and fibronectin in the same way. Mix 27 µL of stock 1 mg/mL laminin 
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and 423 µL of NB media. Label as 60 µg/mL of laminin.  
4. Repeat step 3 for fibronectin and place in a separate tube.  
5. Prepare laminin and fibronectin in the same way. Mix 26 µL of stock 1 mg/mL laminin 
and 624 µL of NB media. Label as 40 µg/mL of laminin.  
6. Repeat step 5 for fibronectin and place in a separate tube.  
7. Place 70 µL of 60 µg/mL of ECM protein into their appropriate microfuge tubes; this 
amount corresponds to the tubes designated to make 4% alginate. There should be 6 
tubes for each ECM protein at a given concentration (6 for laminin, 6 for 
fibronectin). Mix well by vortexing before final use.  
8. Place 100 µL of 40 µg/mL of ECM protein into their appropriate microfuge tubes; this 
amount corresponds to the tubes designated to make 3% alginate. There should be 6 
tubes for each ECM protein at a given concentration (6 for laminin, 6 for 
fibronectin).  
9. Make sure these aliquots remain cold by placing on ice or into the fridge.  
Note: It is suggested to work on laminin and fibronectin first. At this point, please look to 
the plating and gelation step.  
10. Place 40 µL of cold 10X PBS and 2 µL of cold 1M NaOH into each aliquot marked 
for the collagen plates; these amounts are universal regardless of final alginate 
concentration.  
11. Place 67 µL of stock 3 mg/mL collagen into each aliqot marked for the collagen 
plates; this amount is universal regardless of final alginate concentration.  
Note: Before moving forward, due to the gelation of two different gels, it may be best to 
work on one column (one aliquot) at a time and then proceed to plating and gelation 
process before moving on.  
12. Vortex and place immediately on ice. Once steps 6 and 7 are done for one aliquot; it 
is recommended to proceed to plating before making a second aliquot.  
  
Plating & Gelation:  
Note: Each aliquot for each column is “good” for 6 wells with a 100 µL excess.  
1. Take aliquot for one row and add the required amount of cell solution at the indicated 
cell density; breakdown for cell solution amounts and cell density provided in 
Aliquot Breakdown section. Note: aliquots for ALL row B’s should have NO cells.  
2. Gently and thoroughly mix by pipetting solution up and down.  
3. Work quickly so as to maintain cool temperature to avoid unstable gelation of alginate.  
4. Place 96-well plate on top of a relatively flat sterilized Ziplock bag containing ice to 
keep the well plate cool.  
5. Place 50 µL of aliquoted solution into each well for the designated row. For this 
experiment, a triplicate of columns will be filled for each row. Please see Figure 1 
for visual configuration of the well plate.  
6. Since this experiment requires two identical plates for each condition; repeat step 5 for 
the plate’s “twin”.  
Note: For the laminin and fibronectin plates, it may not be necessary to immediately add 
100 mM CaCl2 to each well after a row has been completed. Depending on speed, 
accuracy, and level of comfort in switching out plates, 3 rows is prescribed as a 
suitable interval between CaCl2 addition and removal. For collagen, it is 
recommended to add 100 mM CaCl2 after each row is completed on both twin 
plates.  
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7. Once a particular set of rows has been filled; add 100 µL of cool 100 mM CaCl2 to 
begin alginate gelation. 8. Let it sit on makeshift ice pack for 10 minutes before 
proceeding. This would be a good time to move onto the next row; and alternating 
back and forth as each 10 minute interval has passed.  
9. Once 10 minutes has passed, remove 50 µL from each well and add 50 µL of NB 
media on top.  
10. Once all wells are done (including Controls) place in 37°C and 5% CO2 incubator for 
three days.  
  
Aliquot Breakdown:  
LABELING METHOD: (ECM of use) + (Alginate percentage) + (Row ID); Example: 
C4B (Collagen Plate(s), 4% Alginate base, and Row B.  
  
PLATES ONE & TWO (ALGINATE-COLLAGEN):  
 
4% Alginate (High):  
Row B: 267 µL 6% stock alginate + 40 µL of 10X PBS + 67 µL 3 mg/mL Collagen + 2 
µL 1M  
NaOH + 24 µL of NB Media  
Row C: 267 µL 6% stock alginate + 40 µL of 10X PBS + 67 µL 3 mg/mL Collagen + 2 
µL 1M NaOH + 24 µL of 3.3*105 cells/mL  
Row D: 267 µL 6% stock alginate + 40 µL of 10X PBS + 67 µL 3 mg/mL Collagen + 2 
µL1M NaOH + 24 µL of 1.33*106 cells/mL  
Row E: 267 µL 6% stock alginate + 40 µL of 10X PBS + 67 µL 3 mg/mL Collagen + 2 
µL 1M NaOH + 24 µL of 2.67*106 cells/mL  
Row F: 267 µL 6% stock alginate + 40 µL of 10X PBS + 67 µL 3 mg/mL Collagen + 2 
µL 1M NaOH + 24 µL of 4.0*106 cells/mL  
Row G: 267 µL 6% stock alginate + 40 µL of 10X PBS + 67 µL 3 mg/mL Collagen + 2 
µL 1M NaOH + 24 µL of 8.3*106 cells/mL  
  
3% Alginate (Low):  
Row B: 200 µL 6% stock alginate + 40 µL of 10X PBS + 67 µL 3 mg/mL Collagen + 2 
µL 1M NaOH + 91 µL of NB Media  
Row C: 200 µL 6% stock alginate + 40 µL of 10X PBS + 67 µL 3 mg/mL Collagen + 2 
µL 1M NaOH + 91 µL of 8.8*104 cells/mL  
Row D: 200 µL 6% stock alginate + 40 µL of 10X PBS + 67 µL 3 mg/mL Collagen + 2 
µL 1M NaOH + 91 µL of 3.5*105 cells/mL  
Row E: 200 µL 6% stock alginate + 40 µL of 10X PBS + 67 µL 3 mg/mL Collagen + 2 
µL 1M NaOH + 91 µL of 7.0*105 cells/mL  
Row F: 200 µL 6% stock alginate + 40 µL of 10X PBS + 67 µL 3 mg/mL Collagen + 2 
µL 1M NaOH + 91 µL of 1.05*106 cells/mL  
Row G: 200 µL 6% stock alginate + 40 µL of 10X PBS + 67 µL 3 mg/mL Collagen + 2 
µL 1M NaOH + 91 µL of 2.2*106 cells/mL  
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 PLATE THREE & FOUR (ALGINATE-LAMININ):  
  
4% Alginate (High):  
Row B: 267 µL 6% stock alginate + 70 µL of 60 µg/mL Laminin + 63 µL of NB Media  
Row C: 267 µL 6% stock alginate + 70 µL of 60 µg/mL Laminin + 63 µL of 1.27*105 
cells/mL  
Row D: 267 µL 6% stock alginate + 70 µL of 60 µg/mL Laminin + 63 µL of 5.08*105 
cells/mL  
Row E: 267 µL 6% stock alginate + 70 µL of 60 µg/mL Laminin + 63 µL of 1.02*106 
cells/mL  
Row F: 267 µL 6% stock alginate + 70 µL of 60 µg/mL Laminin + 63 µL of 1.52*106 
cells/mL  
Row G: 267 µL 6% stock alginate + 70 µL of 60 µg/mL Laminin + 63 µL of 3.17*106 
cells/mL  
  
3% Alginate (Low):   
Row B: 200 µL 6% stock alginate + 100 µL of 40 µg/mL Laminin + 100 µL of NB 
Media  
Row C: 200 µL 6% stock alginate + 100 µL of 40 µg/mL Laminin + 100 µL of 8.0*104 
cells/mL  
Row D: 200 µL 6% stock alginate + 100 µL of 40 µg/mL Laminin + 100 µL of 3.2*105 
cells/mL  
Row E: 200 µL 6% stock alginate + 100 µL of 40 µg/mL Laminin + 100 µL of 6.4*105 
cells/mL  
Row F: 200 µL 6% stock alginate + 100 µL of 40 µg/mL Laminin + 100 µL of 9.6*105 
cells/mL  
Row G: 200 µL 6% stock alginate + 100 µL of 40 µg/mL Laminin + 100 µL of 2.0*106 
cells/mL  
  
PLATES FIVE & SIX (ALGINATE-FIBRONECTIN):   
4% Alginate (High):  
Row B: 267 µL 6% stock alginate + 70 µL of 60 µg/mL Fibronectin + 63 µL NB Media  
Row C: 267 µL 6% stock alginate + 70 µL of 60 µg/mL Fibronectin + 63 µL of 1.27*105 
cells/mL  
Row D: 267 µL 6% stock alginate + 70 µL of 60 µg/mL Fibronectin + 63 µL of 5.08*105 
cells/mL  
Row E: 267 µL 6% stock alginate + 70 µL of 60 µg/mL Fibronectin + 63 µL of 1.02*106 
cells/mL  
Row F: 267 µL 6% stock alginate + 70 µL of 60 µg/mL Fibronectin + 63 µL of 1.52*106 
cells/mL  
Row G: 267 µL 6% stock alginate + 70 µL of 60 µg/mL Fibronectin + 63 µL of 3.17*106 
cells/mL  
  
3% Alginate (Low):   
Row B: 200 µL 6% stock alginate + 100 µL of 40 µg/mL Fibronectin + 100 µL of NB 
Media  
Row C: 200 µL 6% stock alginate + 100 µL of 40 µg/mL Fibronectin + 100 µL of 
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8.0*104 cells/mL  
Row D: 200 µL 6% stock alginate + 100 µL of 40 µg/mL Fibronectin + 100 µL of 
3.2*105 cells/mL  
Row E: 200 µL 6% stock alginate + 100 µL of 40 µg/mL Fibronectin + 100 µL of 
6.4*105 cells/mL  
Row F: 200 µL 6% stock alginate + 100 µL of 40 µg/mL Fibronectin + 100 µL of 
9.6*105 cells/mL  
Row G: 200 µL 6% stock alginate + 100 µL of 40 µg/mL Fibronectin + 100 µL of 
2.0*106 cells/mL  
 
 
Figure 17. Experiment 3 configuration. Rows B through G correspond to cell density  
gradient grown on alginate-ECM protein composites. Colors refer to percentage of alginate. 
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Appendix I: Experiment 4 and 5 Protocol 
  
TITLE         ECM Protein Density in 2D and 3D 
  
PURPOSE  To assess which ECM protein- collagen, laminin, or fibronectin- promotes 
the best neuron survival and axon growth by itself, and obtain 2D control 
WST-8 data for comparison. 
  
DATE          1/31/2014 
  
MATERIALS 
  
Lab Supplies: 
2 round bottom 96-well plates 
2 flat bottom 96-well plates 
P1000, P200, P20 pipettes and tips 
2 15 mL centrifuge tubes 
1 50 mL tube 
28 1.5 microfuge tubes 
  
Reagents: 
2.4 mL 500 mM CaCl2 
1.75 mL 9% alginate 
1.05 mL 1X PBS 
63.75 μL 1 mg/mL fibronectin 
63.75 μL 1 mg/mL laminin 
At least 15 mL Neurobasal media containing pen-strep and B-27 supplement 
  
METHODS 
  
Preparation: 
1.         Prepare 100 mM CaCl2: 2.4 mL 500 mM CaCl2 + 9.6 mL NB 
2.         Prepare aliquots according to the aliquot breakdown 
3.         Place aliquots on ice 
  
Plating (3D): 
1.         Add 3x10
5
 cells/mL solution to the aliquot for each column 
2.         Mix by pipetting up and down 
3.         Work quickly to stay cool 
4.         Place plate on ice 
5.         Put 50 μL of each aliquot into wells, in quadruplicate 
6.         Repeat for twin plate 
7.         Add 100 μL cool 100 mM CaCl2 to each gel 
8.         Sit 10 minutes 
9.         Remove 50 μL, add 50 μL NB 
10.     Place in 37°C, 5% CO2 for 3 days 
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Plating (2D): 
1.         Determine volume needed to coat the well floors 
2.         Dilute 10X PBS to 1X PBS: 200 μL PBS + 1.8 mL water 
3.         Place solutions in flat bottomed wells 
4.         Coat the twin plate 
5.         Plate the control in column 1 with PBS/NB 
6.         Allow plates to sit in incubator to dry 
7.         Make 5 mL cell solution at 1x10
5
 cells/mL 
8.         Place 50 μL 1x105 cells/mL in each well 
9.         Top with 100 μL Neurobasal media 
  
Aliquot Breakdown: 
 
LABELING METHOD: (ECM of use) + (ECM percentage) + (Col ID); Example: C4B = 
Collagen, Low, Col 2 
 
PLATES ONE & TWO: 
Control 2: 100 µL 9% stock alginate + 30 µL of 10X PBS + 1 µL 3 mg/mL Collagen + 
0.25 µL 0.1M NaOH + 144 µL of NB Media 
Control 3: 100 µL 9% stock alginate + 30 µL of 10X PBS + 10 µL 3 mg/mL Collagen + 
0.25 µL 1M NaOH + 159.75 µL of NB Media 
Control 4: 100 µL 9% stock alginate + 30 µL of 10X PBS + 50 µL 3 mg/mL Collagen + 
1.25 µL 1M NaOH + 118.75 µL of NB Media 
Column 2: 150 µL 9% stock alginate + 45 µL of 10X PBS + 1.5 µL 3 mg/mL Collagen + 
0.375 µL 0.1M NaOH + 103.125 µL of NB Media + 150 µL of 3.0*105 cells/mL 
Column 3: 150 µL 6% stock alginate + 45 µL of 10X PBS + 15 µL 3 mg/mL 
Collagen + 0.375 µL 1M NaOH + 89.625 µL of NB Media + 150 µL of 3.0*105 
cells/mL 
Column 4: 150 µL 6% stock alginate + 45 µL of 10X PBS + 75 µL 3 mg/mL 
Collagen + 2 µL 1M NaOH + 28 µL of NB media+ 150 µL of 3.0*105 cells/mL 
Control 5: 100 µL 9% stock alginate + 200 µL of NB Media 
Column 5: 150 µL 9% stock alginate + 150 µL of NB Media + 150 µL of 3.0*105 
Control 6: 100 µL 9% stock alginate + 100 µL of 30 µg/mL Fibronectin + 100 µL of NB 
Media 
Control 7: 100 µL 9% stock alginate + 100 µL of 75 µg/mL Fibronectin + 100 µL of NB 
Media 
Control 8: 100 µL 9% stock alginate + 100 µL of 150 µg/mL Fibronectin + 100 µL of 
NB Media 
Column 6: 150 µL 9% stock alginate + 150 µL of 30 µg/mL Fibronectin + 150 µL of 
3.0*105 cells/mL 
Column 7: 150 µL 9% stock alginate + 150 µL of 75 µg/mL Fibronectin + 150 µL of 
3.0*105 cells/mL 
Column 8: 150 µL 9% stock alginate + 150 µL of 150 µg/mL Fibronectin + 150 µL 
of 3.0*105 cells/mL 
Control 9: 100 µL 9% stock alginate + 100 µL of 30 µg/mL Laminin + 100 µL of NB 
Media 
Control 10: 100 µL 9% stock alginate + 100 µL of 75 µg/mL Laminin + 100 µL of NB 
I-3 
Media 
Control 11: 100 µL 9% stock alginate + 100 µL of 150 µg/mL Laminin + 100 µL of NB 
Media 
Column 9: 150 µL 9% stock alginate + 150 µL of 30 µg/mL Laminin + 150 µL of 
3.0*105 cells/mL 
Column 10: 150 µL 9% stock alginate + 150 µL of 75 µg/mL Laminin + 150 µL of 
3.0*105 cells/mL 
Column 11: 150 µL 9% stock alginate + 150 µL of 150 µg/mL Laminin + 150 µL of 
3.0*105  cells/mL 
 
 
 
Figure 18. Experiment 4 and 5 configuration. Rows B and G across all columns refer to control wells, 
while Rows D-G contain cells. Colors refer to amount of ECM protein included. 
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Appendix J: Experiment 6 Protocol 
 
TITLE 2D Cell Density and Assay Signal Determination 
 
PURPOSE To determine the appropriate cell density for viability assays (MTT, WST-
8) in 2D  
 
DATE  2/7/2014 
 
MATERIALS 
 
Lab Supplies: 
2 96-well plate (flat-bottomed) 
Ice bucket, ice in ziplock bag 
P-1000, P-200, P-20, P-10 pipettes and pipette tips 
5 mL serological pipettes and pipette gun 
2 15 mL centrifuge tubes 
16 sterile 1.6 mL microcentrifuge tubes 
At least 20 mL of Neurobasal media containing pen-strep and B-27 supplement 
 
Reagents: 
150 µL of stock 3 mg/mL collagen 
5 mL 1X PBS 
10 µL of 1M sterile NaOH, 150 µL of 10X sterile PBS 
75 µL of 1 mg/mL laminin and fibronectin 
 
METHODS 
 
Dissection: 
Follow the protocols outlined in the Chick Embryo Dissection document. Take note of 
Hamburger and Hamilton embryonic stages. Ideally, want chick embryos between the 
stages of 25 and 30. 
Note: Please keep every solution on ICE. This is most important for solutions that will be 
mixed with stock collagen prior to gelation. Remember that collagen gels when exposed 
to neutral pH and relatively warm temperatures.  
 
Aliquot Preparation: 
1. Prepare aliquots for all setups as indicated in the aliquot breakdown. 
2. Make sure these aliquots remain cold by placing on ice or into the fridge when not in 
use. 
Note: It is suggested to work on laminin and fibronectin first. At this point, please look to 
the plating and gelation step. 
3. Mix collagen aliquots last and just prior to coating plates. Mix stock collagen, 1M 
NaOH and 10X PBS into 1X PBS and vortex before plating. 
4. Steps 1-3 can be done hours in advance of dissection and cell aliquot preparation. 
When  
ready for coating, please proceed to coating step. 
J-2 
5. Prepare cell aliquots as indicated in aliquot breakdown section. 
 
Coating & Plating (2D): 
1. Make aliquots for each column as prescribed in the aliquot breakdown. 
2. Make sure to coat both “twin” plates so as to make sure each one is identical. 
3. For column 1, place 35 µL of 1X PBS and try to keep it as close to the center of the 
96-well plate as possible. 
4. Before working with collagen, proceed to plate fibronectin and laminin wells first. 
5. Place 35 µL of each respective aliquot to its designated columns. 
6. Once both plates are properly and evenly coated, place in incubator prior to use. It is 
preferred to do this hours prior to use; however, ensure that laminin wells do not 
completely evaporate as protein denaturation may occur. 
7. When ready for use, plating may begin by placing 50 µL of respective cell density to 
its designated row. (Please see aliquot breakdown). 
8. When each well is properly added with cell solution, top off each well with 100 µL of 
NB media. 
9. Incubate for three days prior to running MTT and WST assays. 
 
Aliquot Breakdown: 
 
PLATE ONE & TWO (2D): 
Note: Each well will be coated with 35 µL of diluted ECM solution. 
 
ECM: 
Column 2: 450 µL of 1X PBS 
Column 3: 45 µL of 10X PBS + 75 µL of 3.0 mg/mL collagen + 1.875 µL 1M NaOH + 
328.125 µL 1X PBS 
Column 4: 45 µL of 10X PBS + 75 µL of 3.0 mg/mL collagen + 1.875 µL 1M NaOH + 
328.125 µL 1X PBS 
Column 5: 45 µL of 10X PBS + 75 µL of 3.0 mg/mL collagen + 1.875 µL 1M NaOH + 
328.125 µL 1X PBS 
Column 6: 22.5 µL of 1 mg/mL fibronectin + 427.5 µL 1X PBS 
Column 7: 22.5 µL of 1 mg/mL fibronectin + 427.5 µL 1X PBS 
Column 8: 22.5 µL of 1 mg/mL fibronectin + 427.5 µL 1X PBS 
Column 9: 22.5 µL of 1 mg/mL laminin + 427.5 µL 1X PBS 
Column 10: 22.5 µL of 1 mg/mL laminin + 427.5 µL 1X PBS 
Column 11: 22.5 µL of 1 mg/mL laminin + 427.5 µL 1X PBS 
 
Cells: 
Note: Each aliquot of cells is good for 20 wells, with an excess of 200 µL of cell solution. 
Row B: 1.2 mL of NB Media (0 cells/well) 
Row C: 1.2 mL of 1.0 * 105 cells/mL (5000 cells/well) 
Row D: 1.2 mL of 1.0 * 106 cells/mL (50000 cells/well) 
Row E: 1.2 mL of 2.0 * 106 cells/mL (100000 cells/well) 
Row F: 1.2 mL of 3.0 * 106 cells/mL (150000 cells/well) 
Row G: 1.2 mL of 4.0 * 106 cells/mL (200000 cells/well) 
 
J-3 
 
Figure 19. Experiment 6 configuration. Row B across all columns refers to control wells containing the no 
cells. Colors refer to cell density gradient. 
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Appendix K: Experiment 7 Protocol 
 
TITLE Toxicity in 2D and 3D laminin, for assaying 
 
PURPOSE To determine the CT-50 of acrylamide on primary neurons and glia 
derived from chick embryo spinal cords when cultured on 2D laminin-
coated wells and 3D alginate-laminin hydrogels.  
 
DATE  2/14/2014  
 
MATERIALS 
  
Lab Supplies: 
1 each of 96-well plate flat-bottomed and u-bottomed 
Ice bucket, ice in ziplock bag  
P-1000, P-200, P-20, P-10 pipettes and pipette tips  
5 mL serological pipettes and pipette gun  
2 15 mL centrifuge tubes.  
15 sterile 1.6 mL microcentrifuge tubes  
 
Reagents: 
0.5 mL stock 500 mM CaCl2  
At least 15-20 mL of Neurobasal media containing pen-strep and B-27 supplement  
0.5 mL of stock 9% alginate  
0.5 mL 1X PBS  
100 µL of 1 mg/mL laminin  
 
METHODS  
 
Dissection:  
Please follow the protocols outlined in the Chick Embryo Dissection document. Take 
note of Hamburger and Hamilton embryonic stages. Ideally, want chick embryos between 
the stages of 25 and 30.  
Note: Please keep cell solution on ICE. Use of Trypan Blue is recommended, but likely 
unnecessary.  
 
Aliquot Preparation:  
1. Prepare 100 mM CaCl2 by taking 0.4 mL stock 500 mM CaCl2 and placing into a 15 
mL centrifuge tube and then adding 1.6 mL Neurobasal media. Place into the fridge 
or ice bucket immediately and replace between each use. (Good for 20 wells).  
2. Prepare aliquots for all setups as explained in the aliquot breakdown section.  
3. Prepare laminin for 2D by mixing 35 µL of stock 1 mg/mL laminin and 665 µL of 1X 
PBS to make 50 µg/mL laminin.  
4. Vortex 2D laminin and proceed to 2D plate preparation in Plating & Gelation Step 
(Steps 1 and 2).  
 
5. Aliquot 67 µL of stock 9% alginate into 6 separate microfuge tubes labeled B through 
K-2 
G.  
6. Prepare laminin for 3D by mixing 63 µL of stock 1 mg/mL laminin and 357 µL of 
Neurobasal to make 150 µg/mL laminin.  
7. Vortex 3D laminin and place 67 µL of 150 µg/mL laminin into each of the 3D 
aliquots. Place on ice or freezer prior to use.  
 
Plating & Gelation:  
Note: Each aliquot for each column is “good” for 6 wells with a 100 µL excess.   
1. Properly label a 96-well flat-bottomed plate and take aliquots for 2D plate preparation 
and add 35 µL of 50 µg/mL laminin and add to each well in columns 2-4 and rows 
B-G; please see figure X. 2. Let plate sit in incubator prior to use to allow for partial 
drying; be careful to avoid drying out laminin wells as it may lead to the protein 
denaturing.  
3. Once cells are ready and counted, prepare 0.5 mL of 4.5*106  for 3D plates and 
prepare 1.2 mL of 1.5*106 cells/mL for 2D plates. 
4. Add 50 µL of 1.5*106 cells/mL to each well in the 2D plate and then top off with 100 
µL of Neurobasal media.  
5. Place in 37°C and 5% CO2 incubator for three days.  
6. Thaw out 3D alginate-laminin aliquots and keep relatively cool.  
7. Properly label a 96-well u-bottomed plate and place on top of a relatively flat sterilized 
Ziplock bag containing ice to keep the well plates cool.  
8. Add 67 µL of 4.5*106 to the 3D aliquots and gently mix. Keep aliquots on ice to 
preserve cells.  
9. Take one aliquot and make triplicate wells in row B, columns 2-4, by putting 50 µL of 
the aliquot and placing them in each well. Top off with 100 µL of 100 mM CaCl2 
for ~10 minutes. Proceed to the next row and continue until time to remove CaCl2.  
10. Once a well has been treated with CaCl2 for 10 minutes, remove 50 µL of solution 
from the top and replace with 50 µL of Neurobasal media. Continue until all wells 
have been filled for rows B-G and columns 2-4.  
11. Once all wells are done, place in 37°C and 5% CO2 incubator for three days.  
 
Aliquot Breakdown:  
 
PLATE ONE (LAMININ):  
Note: aliquots are good for 18 wells with a 100 µL excess for ECM and 200 µL excess 
for cells.  
 
ECM:  
All: 35 µL of 1 mg/mL Laminin + 665 µL of 1X PBS.  
 
Cells:  
All: 1.2 mL of 1.5*106 
 
PLATE TWO (ALGINATE-LAMININ):  
Note: aliquots are good for triplicates and an excess of ~ 50 µL  
 
Row B: 67 µL 9% stock alginate + 67 µL of 150 µg/mL Laminin + 67 µL of 4.5*106 
K-3 
cells/mL 
Row C: 67 µL 9% stock alginate + 67 µL of 150 µg/mL Laminin + 67 µL of 4.5*106 
cells/mL 
Row D: 67 µL 9% stock alginate + 67 µL of 150 µg/mL Laminin + 67 µL of 4.5*106 
cells/mL 
Row E: 67 µL 9% stock alginate + 67 µL of 150 µg/mL Laminin + 67 µL of 4.5*106 
cells/mL 
Row F: 67 µL 9% stock alginate + 67 µL of 150 µg/mL Laminin + 67 µL of 4.5*106 
cells/mL 
Row G: 67 µL 9% stock alginate + 67 µL of 150 µg/mL Laminin + 67 µL of 4.5*106 
cells/mL 
 
 
 
Figure 20. Experiment 7 Configuration. Gradient refers to the amount of acrylamide added to each well. 
Row G contains no acrylamide and will serve as the control well. Figure 1 corresponds with both the 2D 
and 3D plate. 
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Appendix L: Experiment 8 Protocol 
 
TITLE Analysis of U87 cells in 2D and 3D Collagen 
 
PURPOSE To determine the viability of U87’s cultured on pure collagen hydrogels 
using two distinct assays: MTT and WST-8. 
 
DATE  2/28/2014 
 
MATERIALS 
 
Lab Supplies: 
2 each of 96-well plate flat-bottomed and u-bottomed 
Ice bucket, ice in ziplock bag 
P-1000, P-200, P-20, P-10 pipettes and pipette tips 
2 15 mL centrifuge tubes 
 
Reagents: 
6 sterile 1.6 mL microcentrifuge tubes 
At least 10 mL of Neurobasal media containing pen-strep and B-27 supplement 
100 µL 10X PBS 
10 µL of 1M NaOH 
500 µL of 3 mg/mL collagen stock solution 
 
METHODS 
 
Passaging: 
Note: Please keep cell solution and neutralized collagen on ICE.  
1. Obtain 10 cm plate with highly confluent U87 cells. 
2. Aspirate off media; then add 3 mL of warm 1X PBS. 
3. Aspirate off PBS; then add 3 mL of warm Trypsin-EDTA. 
4. Incubate for 3 mins; then add 5 mL of Warm NB Media. 
5. Collect cells in 15 mL centrifuge tube and centrifuge at 1.5 power for 5 minutes. 
6. Aspirate off supernatant, dilute accordingly and resuspend pellet. 
7. Count cells using a hemocytometer (Trypan blue recommended). 
8. Re-plate left over cells in another 10 cm plate with appropriate density based on 
duration until next use. 
 
Aliquot Preparation: 
9. Prepare aliquots for all setups as explained in the aliquot breakdown section. 
10. Vortex neutralized collagen prior to cell addition for 3D and prior to 2D coating. 
11. Keep neutralized collagen cold. 
 
Plating & Gelation: 
Note: Each aliquot for each column is “good” for 6 wells with a 100 µL excess. 
1. Properly label 2 96-well flat-bottomed plates and take aliquots for 2D plate preparation 
and add 35 µL of 1 mg/mL collagen and add to each well in columns 2-4 and rows B 
M-2 
and C. 
2. Let plate sit in incubator prior to use to allow for partial drying. 
3. Once cells are ready and counted, prepare 0.2 mL of 4.5*106 prepare 0.5 mL of 
1.5*106 cells/mL for 2D plates. 
4. Add 50 µL of 1.5*106 cells/mL to each well in the 2D plate and then top off with 100 
µL of Neurobasal media. 
5. Place in 37°C and 5% CO2 incubator for three days. 
6. Properly label a 96-well u-bottomed plate and place on top of a relatively flat sterilized 
Ziplock bag containing ice to keep the well plates cool. 
7. Add 133 µL of 4.5*106 cells/mL to the 3D aliquots and gently mix. Keep aliquots on 
ice to preserve cells. 
8. Take aliquot for row B and make triplicate wells in row B, columns 2-4, by putting 50 
µL of the aliquot and placing them in each well. Repeat for twin plate. 
9. Take aliquot for row C and make triplicate wells in row C, columns 2-4, by putting 50 
µL of the aliquot and placing them in each well. Repeat for twin plate. 
10. Top off all 3D plates with 100 µL of NB Media. 
 
Aliquot Breakdown: 
 
PLATES ONE + TWO (2D WST-8 + MTT Assay): 
 
ECM: 
117 µL 3 mg/mL stock collagen + 35 µL 10X PBS + 3 µL 1M NaOH + 195 µL of NB 
Media 
 
Cells: 
500 µL of 1.5*106 cells/mL 
 
PLATE THREE + FOUR (3D WST-8 + 3D MTT Assay) 
Note: aliquots are good for triplicates for each plate and an excess of ~ 100 µL 
Row B: 26.7 µL 10X PBS + 133.5 µL of 3 mg/mL stock collagen + 3.3 µL 1M NaOH + 
103.5 µL of NB Media + 133 µL of 4.5*106 cells/mL 
Row C: 26.7 µL 10X PBS + 133.5 µL of 3 mg/mL stock collagen + 3.3 µL 1M NaOH + 
103.5 µL of NB Media + 133 µL of NB Media 
 
M-3 
 
 
Figure 21. Experiment 8 Configuration. Plate setup is the same for 3D and 2D. Two plates will be made 
for each dimension; 4 total. Color corresponds with amount of cells in each row. 
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Appendix M: Experiment 9 Protocol 
 
TITLE Toxicity on 2D laminin and collagen, for assaying and visualization 
 
PURPOSE To determine the CT-50 and extent of axon retraction due to acrylamide 
exposure to primary neurons and glia derived from chick embryo spinal 
cords when cultured on 2D collagen and laminin-coated wells; 
Preliminary testing of feasibility of WST-8 assay on pure collagen gels as 
well as viewing extension in pure collagen.  
 
DATE  2/28/2014 
 
MATERIALS 
 
Lab Supplies: 
1 each of 96-well plate flat-bottomed and u-bottomed 
Ice bucket, ice in ziplock bag 
P-1000, P-200, P-20, P-10 pipettes and pipette tips 
5 mL serological pipettes and pipette gun 
2 15 mL centrifuge tubes. 
10 sterile 1.6 mL microcentrifuge tubes 
 
Reagents: 
At least 15-20 mL of Neurobasal media containing pen-strep and B-27 supplement 
1X PBS, 10X PBS, 1M NaOH 
65 µL of 1 mg/mL laminin 
0.75 mL of 3 mg/mL stock collagen 
 
METHODS 
 
Dissection: 
Follow the protocols outlined in the Chick Embryo Dissection document.Take note of 
Hamburger and Hamilton embryonic stages. Ideally, want chick embryos between the 
stages of 25 and 30.  
Note: Please keep cell solution and neutralized collagen on ICE. Use of Trypan Blue is 
recommended, but likely unnecessary.  
 
Aliquot Preparation: 
1. Prepare aliquots for all setups as explained in the aliquot breakdown section. 
2. Vortex 2D laminin and proceed to 2D plate preparation in Plating & Gelation Step 
(Steps 1 and 2). 
3. Vortex 2D neutralized collagen and repeat 2D plate preparation.  
 
Plating & Gelation: 
Note: Each aliquot for each column is “good” for 6 wells with a 100 µL excess. 
1. Properly label two 96-well flat-bottomed plates and take aliquots for 2D plate 
preparation and add 35 µL of 50 µg/mL laminin OR 1 mg/mL collagen and add to 
M-2 
each well in columns 2-4 and rows B-G (rows B-F for 2D Tox Vis plate); please see 
figures 1 and 2. 
2. Let plate sit in incubator prior to use to allow for partial drying; be careful to avoid 
drying out laminin wells as it may lead to the protein denaturing. 
3. Once cells are ready and counted, prepare 2.1 mL of 1.5*106plate, 1.8 mL of 4.0*105 
cells/mL for 2D Tox Vis plate, and 150 µL each of 1.5*106 mL and 8.0*106 
cells/mL for 3D Assay and Vis. 
4. Add 50 µL of 1.5*106 cells/mL to each well in the 2D Tox Assay plate and then top 
off  with 100 µL of Neurobasal media. 
5. Add 50 µL of 4.0*105 cells/mL to each well in the 2D Tox Vis plate and then top off 
with 100 µL of Neurobasal media. 
6. Place in 37°C and 5% CO2 incubator for three days. 
7. Prepare neutralized collagen aliquots as indicated in the aliquot breakdown section. 
8. Properly label a 96-well u-bottomed plate and place on top of a relatively flat sterilized 
Ziplock bag containing ice to keep the well plates cool. 
9. Take aliquot for row B (3D Assay) and make triplicate wells in columns 2-4, by 
putting 50 µL of the aliquot and placing them in each well. Top off with 100 µL of 
NB Media. 
10. Take aliquot for row C (3D Control) and make triplicate wells in columns 2-4, by 
putting 50 µL of the aliquot and placing them in each well. Top off with 100 µL of 
NB Media. 
11. Take aliquot for row D (3D Vis) and make triplicate wells in columns 2-4, by putting 
50 µL of the aliquot and placing them in each well. Top off with 100 µL of NB 
Media. 
12. Once all wells are done, place in 37°C and 5% CO2 incubator for three days. 
 
Aliquot Breakdown: 
 
PLATES ONE + TWO (2D Tox Assay and Tox Visualization Plate): 
Note: aliquots are good for 33 wells with a 145 µL excess for both ECM proteins and 300 
µL excess for both cell aliquots. 
 
Collagen: 
All: 433 µL of 3 mg/mL stock collagen + 11 µL of 1M NaOH + 130 µL of 10X PBS + 
726 µL of 1X PBS 
 
Laminin: 
All: 65 µL of 1 mg/mL Laminin + 1235 µL of 1X PBS 
 
Cells: 
 
2D Tox Assay Plate: 2.1 mL of 1.5*106 cells/mL 
2D Tox Visual Plate: 1.8 mL of 4.0*105 cells/mL 
 
PLATE THREE (3D Collagen Plate): 
Note: aliquots are good for 3 wells with a 50 µL excess. 
 
M-3 
Row B: 10 µL 10X PBS + 67 µL of 3 mg/mL stock collagen + 1.7 µL 1M NaOH + 21.3 
µL of NB Media + 100 µL of 3.0*106 cells/mL 
Row C: 10 µL 10X PBS + 67 µL of 3 mg/mL stock collagen + 1.7 µL 1M NaOH + 121.3 
µL of NB Media 
Row D: 10 µL 10X PBS + 67 µL of 3 mg/mL stock collagen + 1.7 µL 1M NaOH + 21.3 
µL of NB Media + 100 µL of 8.0*105 cells/mL 
 
 
 
Figure 22a. Experiment 9 2D toxicity assay and visualization plates configuration. Gradient refers to the 
amount of acrylamide added to each well. Color corresponds to which ECM the wells will be coated with. 
 
        
Figure 22b. Experiment 9 3D plate configuration. Color corresponds with amount of cells to be added to 
each well. 
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Appendix N: Experiment 10 Protocol 
 
TITLE Toxicity in 3D collagen, for assaying  
 
PURPOSE To determine the CT-50 to acrylamide exposure to primary neurons and 
glia derived from chick embryo spinal cords when cultured on 3D 
collagen using an MTT assay. 
 
DATE       3/7/2014 
  
MATERIALS 
  
Lab Supplies: 
1 each of 96-well plate flat-bottomed and u-bottomed 
Ice bucket, ice in ziplock bag 
P-1000, P-200, P-20, P-10 pipettes and pipette tips 
5 mL serological pipettes and pipette gun 
2 15 mL centrifuge tubes. 
10 sterile 1.6 mL microcentrifuge tubes 
 
Reagents: 
At least 15-20 mL of Neurobasal media containing pen-strep and B-27 supplement 
1X PBS, 10X PBS, 1M NaOH 
0.75 mL of 3 mg/mL stock collagen 
  
METHODS 
 
Dissection: 
Follow the protocols outlined in the Chick Embryo Dissection document. Take note of 
Hamburger and Hamilton embryonic stages. Ideally, want chick embryos between the 
stages of 25 and 30. 
 Note: Please keep cell solution and neutralized collagen on ICE. Use of Trypan Blue is 
recommended, but likely unnecessary. 
  
Aliquot Preparation: 
1.    Prepare aliquots for all setups as explained in the aliquot breakdown section. 
  
Plating & Gelation: 
Note: Each aliquot for each column is “good” for 6 wells with a 100 µL excess. 
  
1.    Prepare neutralized collagen aliquots as indicated in the aliquot breakdown section. 
2.    Properly label a 96-well u-bottomed plate. 
3.    Take aliquot for row B and make triplicate wells in columns 2-4, by putting 50 µL of 
the aliquot and placing them in each well. Top off with 100 µL of NB Media. 
4.    Repeat for rows C-G. 
5.    Once all wells are done, place in 37°C and 5% CO2 incubator for three days. 
  
N-2 
Aliquot Breakdown: 
  
PLATE THREE (3D Collagen Plate): 
Note: aliquots are good for 3 wells with a 50 µL excess. 
  
Row B: 10 µL 10X PBS + 67 µL of 3 mg/mL stock collagen + 1.7 µL 1M NaOH + 21.3 
µL of NB Media + 100 µL of 3.0*10
6
 cells/mL 
Row C: 10 µL 10X PBS + 67 µL of 3 mg/mL stock collagen + 1.7 µL 1M NaOH + 21.3 
µL of NB Media + 100 µL of 3.0*10
6
 cells/mL 
Row D: 10 µL 10X PBS + 67 µL of 3 mg/mL stock collagen + 1.7 µL 1M NaOH + 21.3 
µL of NB Media + 100 µL of 3.0*10
6
 cells/mL 
Row E: 10 µL 10X PBS + 67 µL of 3 mg/mL stock collagen + 1.7 µL 1M NaOH + 21.3 
µL of NB Media + 100 µL of 3.0*10
6
 cells/mL 
Row F: 10 µL 10X PBS + 67 µL of 3 mg/mL stock collagen + 1.7 µL 1M NaOH + 21.3 
µL of NB Media + 100 µL of 3.0*10
6
 cells/mL 
Row G: 10 µL 10X PBS + 67 µL of 3 mg/mL stock collagen + 1.7 µL 1M NaOH + 21.3 
µL of NB Media + 100 µL of 3.0*10
6
 cells/mL 
 
 
Figure 23. Experiment 10 toxicity assay plate configuration. Gradient refers to the amount of acrylamide 
added to each well. Color corresponds to which ECM the wells will be coated with. 
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Appendix O: Experiment 12 Protocol 
 
TITLE         Toxicity in 3D collagen, for visualization 
  
PURPOSE  To visualize the response to acrylamide toxin in 3D collagen gels in 8-well 
chamber slides; 0.5 and 1 mg/mL collagen, with four levels of toxin. 
Duplicates plates prepared to fix one without toxin and the other after 
toxin addition. 
  
DATE          4/9/2014 
  
MATERIALS 
  
Lab Supplies: 
4 8-well chamber slides 
P1000, P200, P20, P10 pipettes and tips 
  
Reagents: 
3 mg/mL collagen 
10X PBS 
1M NaOH 
1 mL Neurobasal media containing pen-strep and B-27 supplement 
  
METHODS 
  
Dissection: 
Follow the protocols outlined in the Chick Embryo Dissection document. Take note of 
Hamburger and Hamilton embryonic stages. Ideally, want chick embryos between the 
stages of 25 and 30. 
Note: Please keep cell solution and neutralized collagen on ICE. 
  
Plating and gelation: 
1.         Label 4 8-well chamber slides one through four 
2.         Dilute the cell solution to 8x10
5
 cells/mL (final concentration 20,000 cells per 
well) 
3.         For plates 1 and 2 aliquot: 
a. 251 μL NB + 150 μL 3 mg/mL collagen + 45 μL 10X PBS + 4 μL 1M NaOH 
b. Vortex 
c. Add  450 μL 8x105 cells/mL, pipet mix 
4. Plates 3 and 4 aliquot: 
a. 328 μL NB + 75 μL 3 mg/mL collagen + 45 μL 10X PBS + 2 μL 1M NaOH 
b. Vortex 
c. Add  450 μL 8x105 cells/mL, pipet mix 
5. Place 50 μL of gel in each chamber slide well 
6. Incubate for 30 minutes for gelation to occur, then add 100 μL NB media 
  
O-2 
1 mg/mL    
collagen 
        
   
 
      
 
0.5 
mg/mL 
collagen 
        
   
 
      
  
Figure 24. Experiment 12 plate configuration. Gradient refers to the amount of acrylamide added to each 
well: 100 mM, 10 mM, 1 mM, 0 mM. 
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Appendix P: Experiment 13 Protocol 
 
TITLE         Toxicity in 3D collagen, for visualization 
  
PURPOSE  To visualize the response to acrylamide toxin in 3D collagen gels of larger 
volume in 8-well chamber slides; 1 and 2 mg/mL collagen, with four 
levels of toxin. 
  
DATE          4/16/2014 
  
MATERIALS 
  
Lab Supplies: 
4 8-well chamber slides 
P1000, P200, P20, P10 pipettes and tips 
  
Reagents: 
3 mg/mL collagen 
10X PBS 
1M NaOH 
1 mL Neurobasal media containing pen-strep and B-27 supplement 
  
METHODS 
  
Dissection: 
Follow the protocols outlined in the Chick Embryo Dissection document. Take note of 
Hamburger and Hamilton embryonic stages. Ideally, want chick embryos between the 
stages of 25 and 30. 
Note: Please keep cell solution and neutralized collagen on ICE. 
  
Plating and gelation: 
1.         Label 4 8-well chamber slides one through four 
2.         Dilute the cell solution to 8x10
5
 cells/mL and 1.875x10
6
 cells/mL 
3.         For 1 mg/mL aliquot: 
a. 96 μL NB + 567 μL 3 mg/mL collagen + 170 μL 10X PBS + 17 μL 1M NaOH 
b.   Vortex 
c. Add  850 μL 8x105 cells/mL, pipet mix 
4. For 2 mg/mL aliquot: 
a. 1133 μL 3 mg/mL collagen + 170 μL 10X PBS + 34 μL 1M NaOH 
b. Vortex 
c. Add 363 μL 1.875x106 cells/mL, pipet mix 
5. Place 200 μL of gel in each chamber slide well 
6. Incubate for 30 minutes for gelation to occur, then add 100 μL NB media 
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Figure 25. Experiment 13 plate configurations. Gradient refers to the amount of acrylamide added to each 
well: 100 mM, 10 mM, 1 mM, 0 mM. Grey indicates empty wells. 
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Appendix Q: Experiment 14 Protocol 
 
TITLE        Toxicity in 3D collagen, for assaying 
 
PURPOSE To determine the CT-50 to acrylamide exposure of primary neurons and 
glia derived from chick embryo spinal cords when cultured in 0.5, 1, and 2 
mg/mL collagen gels; using an MTT assay. 
 
DATE        4/23/2014 
  
MATERIALS 
 
Lab Supplies: 
1 U-bottomed 96-well plate 
Ice bucket, ice in ziplock bag 
P-1000, P-200, P-20, P-10 pipettes and pipette tips 
5 mL serological pipettes and pipette gun 
2 15 mL centrifuge tubes. 
10 sterile 1.6 mL microcentrifuge tubes 
 
Reagents: 
At least 15-20 mL of Neurobasal media containing pen-strep and B-27 supplement 
1X PBS, 10X PBS, 1M NaOH 
1.2 mL of 3 mg/mL stock collagen 
  
METHODS 
  
Dissection: 
Follow the protocols outlined in the Chick Embryo Dissection document. Take note of 
Hamburger and Hamilton embryonic stages. Ideally, want chick embryos between the 
stages of 25 and 30. 6-7 embryos are needed for this experiment. 
 Note: Keep cell solution and neutralized collagen on ICE. Use of Trypan Blue is 
recommended, but likely unnecessary. 
  
Aliquot Preparation: 
1.    Prepare two cell dilution aliquots: 1.4 mL of 3.0*10
6
 cells/mL and 600 µL of 3.9*10
6
 
cells/mL 
Note: final cell concentration is 75,000 cells per well. 
2.    Prepare neutralized collagen aliquots as indicated in the aliquot breakdown section. 
  
Plating & Gelation: 
3.    Properly label the 96-well u-bottomed plate. 
4.    Add 50 µL of .5B aliquot to triplicate wells in row B, columns 2-4. 
5.    Top off with 100 µL of NB Media. 
6.    Repeat with .5 aliquots for rows C-G. 
7.    Repeat steps 3-5 with the 1 mg/mL aliquots in columns 5-7. 
8.    Repeat steps 3-5 with the 2 mg/mL aliquots in columns 8-10. 
Q-2 
9.    Once all wells are done, place in 37°C and 5% CO2 incubator for three days. 
  
Aliquot Breakdown: 
Note: Aliquots are good for 3 wells with a 50 µL excess. 16 aliquots total. 
  
0.5 mg/mL collagen (columns 2-4) 
.5B: 33 µL 3 mg/mL stock collagen + 5 µL 10X PBS + 0.85 µL 1M NaOH + 61.15 µL of 
NB Media + 100 µL of 3.0*10
6
 cells/mL 
.5C: 33 µL 3 mg/mL stock collagen + 5 µL 10X PBS + 0.85 µL 1M NaOH + 61.15 µL of 
NB Media + 100 µL of 3.0*10
6
 cells/mL 
.5D: 33 µL 3 mg/mL stock collagen + 5 µL 10X PBS + 0.85 µL 1M NaOH + 61.15 µL 
of NB Media + 100 µL of 3.0*10
6
 cells/mL 
.5E: 33 µL 3 mg/mL stock collagen + 5 µL 10X PBS + 0.85 µL 1M NaOH + 61.15 µL of 
NB Media + 100 µL of 3.0*10
6
 cells/mL 
.5F: 33 µL 3 mg/mL stock collagen + 5 µL 10X PBS + 0.85 µL 1M NaOH + 61.15 µL of 
NB Media + 100 µL of 3.0*10
6
 cells/mL 
.5G: 33 µL 3 mg/mL stock collagen + 5 µL 10X PBS + 0.85 µL 1M NaOH + 61.15 µL 
of NB Media + 100 µL of 3.0*10
6
 cells/mL 
  
1 mg/mL collagen (columns 5-7) 
1B: 67 µL 3 mg/mL stock collagen + 10 µL 10X PBS + 1.7 µL 1M NaOH + 21.3 µL of 
NB Media + 100 µL of 3.0*10
6
 cells/mL 
1C: 67 µL 3 mg/mL stock collagen + 10 µL 10X PBS + 1.7 µL 1M NaOH + 21.3 µL of 
NB Media + 100 µL of 3.0*10
6
 cells/mL 
1D: 67 µL 3 mg/mL stock collagen + 10 µL 10X PBS + 1.7 µL 1M NaOH + 21.3 µL of 
NB Media + 100 µL of 3.0*10
6
 cells/mL 
1E: 67 µL 3 mg/mL stock collagen + 10 µL 10X PBS + 1.7 µL 1M NaOH + 21.3 µL of 
NB Media + 100 µL of 3.0*10
6
 cells/mL 
1F: 67 µL 3 mg/mL stock collagen + 10 µL 10X PBS + 1.7 µL 1M NaOH + 21.3 µL of 
NB Media + 100 µL of 3.0*10
6
 cells/mL 
1G: 67 µL 3 mg/mL stock collagen + 10 µL 10X PBS + 1.7 µL 1M NaOH + 21.3 µL of 
NB Media + 100 µL of 3.0*10
6
 cells/mL 
  
2 mg/mL collagen (columns 8-10) 
2B: 100 µL 3 mg/mL stock collagen + 20 µL 10X PBS + 3.4 µL 1M NaOH + 77 µL of 
3.9*10
6
 cells/mL 
2C: 100 µL 3 mg/mL stock collagen + 20 µL 10X PBS + 3.4 µL 1M NaOH + 77 µL of 
3.9*10
6
 cells/mL 
2D: 100 µL 3 mg/mL stock collagen + 20 µL 10X PBS + 3.4 µL 1M NaOH + 77 µL of 
3.9*10
6
 cells/mL 
2E: 100 µL 3 mg/mL stock collagen + 20 µL 10X PBS + 3.4 µL 1M NaOH + 77 µL of 
3.9*10
6
 cells/mL 
2F: 100 µL 3 mg/mL stock collagen + 20 µL 10X PBS + 3.4 µL 1M NaOH + 77 µL of 
3.9*10
6
 cells/mL 
2G: 100 µL 3 mg/mL stock collagen + 20 µL 10X PBS + 3.4 µL 1M NaOH + 77 µL of 
3.9*10
6
 cells/mL 
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Figure 26.  Experiment 14 toxicity assay plate configuration. 
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Appendix R: Supplementary Neuron Culture Analysis Data 
 
 
Figure 27. Ratio of glial cells per neuronal cell, defined as a DAPI-stained cell showing neurofilament-
stained extension(s). Five representative 40X images were taken of each well, and the cells tallied. 
 
Table 8. Axon length values and comparison. 
 
 2 mg/mL 
(0 mM) 
N=17 
2 mg/mL 
(1 mM) 
N=14 
2 mg/mL 
(10 mM) 
N=11 
2 mg/mL 
(100 mM) 
N=8 
Average Axon Length 
(mm) 
183.42 110.26 48.71 17.71 
Min Axon Length (mm) 21.56 33.50 0 0 
Max Axon Length  mm) 669.36 230.93 146.97 101.40 
Std. Dev 155.80 66.72 58.93 36.63 
 
 1 mg/mL 
(0 mM) 
N=17 
1 mg/mL 
(1 mM) 
N=12 
1 mg/mL 
(10 mM) 
N=10 
1 mg/mL 
(100 mM) 
N=9 
Average Axon Length 
(mm) 
53.12 60.67 20.88 0 
Min Axon Length (mm) 4.59 12.68 0 0 
Max Axon Length (mm) 134.43 128.33 116.53 0 
Std. Dev 38.49 40.23 44.39 0 
 
 % Difference between  
1 mg/mL and 2 mg/mL 
0 mM ACR 110.17 
1 mM ACR 58.02 
10 mM ACR 79.99 
100 mM ACR 200 
 
 
 
 1 mg/mL 2 mg/mL 
% Difference between  
0 mM and 1 mM ACR 
13.28 49.82 
% Difference between  
1 mM and 10 mM ACR 
97.58 77.43 
% Difference between 
10 mM and 100 mM 
ACR 
200 93.37 
